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ABSTRACT
Background: Inadequate post-operative analgesia continues to pose a significant challenge in
healthcare. Despite the expansion and application of innovative analgesic approaches over the
past decades, more than 50% of patients experience moderate to severe pain, even after minor
surgical procedures. The trend in anesthesia has been the utilization of rapid-acting opioids such
as fentanyl or shorter-acting opioids such as hydromorphone. The administration of methadone
exerts powerful analgesic effects through potent μ-receptor agonism, N-methyl-D-aspartate
receptor antagonism, and the inhibition of serotonin and noradrenaline reuptake. It has also been
used in several procedures to reduce post-operative pain and post-operative opioid consumption.
Methodology: This quality improvement project composed of 15 randomized control trials
reviewed whether the intraoperative use of methadone lowers post-operative pain scores and
opioid consumption in comparison to other short-acting opioids commonly utilized
intraoperatively. An educational module intervention composed of a pre-assessment survey, a
narrated presentation, and a post-assessment survey will assess anesthesia provider knowledge.
Results: The empirical evidence demonstrated that the administration of single-dose
intraoperative methadone reduced post-operative pain scores and post-operative opioid
consumption 48 hours after surgery compared to other short-acting opioids. Overall, the results
reflect an improvement in methadone knowledge based on the pre-assessment and postassessment survey results. Knowledge showed an average improvement of 11%.
Conclusion: This quality improvement educational module seeks to assess anesthesia providers’
knowledge regarding the clinical effects of single-dose intraoperative methadone. Anesthesia
providers receiving the educational intervention will include Anesthesiologists and Certified
Registered Nurse Anesthetists (CRNA). The sample will include approximately 5 to 10
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participants. The quality improvement project will involve three phases, a pre-assessment survey,
an online educational presentation, and a post-assessment survey. Pre-assessment and postassessment surveys will be used to evaluate the effectiveness of the educational module.
Statistical analysis will be applied to assess the knowledge of the educational intervention. It is
projected that the provider’s education will improve regarding the clinical effect of single-dose
intraoperative methadone.
Key terms: methadone, post-operative pain, post-operative opioid consumption, and
intraoperative analgesia.
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BACKGROUND
Introduction
Post-operative pain remains a widespread and underestimated clinical problem faced by
patients and anesthesia providers. The incidence of post-operative pain can be as high as 80%1
and the incidence of acute post-operative pain transitioning to persistent chronic pain can occur
in 10-15% of patients undergoing surgical procedures.1 The surgical procedures with the high
risk include hernia repair, chest wall surgery, leg amputation, and coronary artery bypass
grafting.1 The incidence of moderate to severe pain, synonymous with unacceptable pain by most
patients, on the first postoperative day, is reported to occur in 30% to 80% of surgical patients.2
Despite advancements in pain management, many patients still suffer from moderate to severe
postoperative pain; leading to decreased patient satisfaction, delayed postoperative ambulation,
development of chronic pain, pulmonary and cardiac complications,3 and increased morbidity
and mortality.4
Conventional opioid therapy depends on shorter-acting drugs such as morphine,
hydromorphone, or fentanyl and its derivatives administered as intermittent boluses or patientcontrolled analgesia (PCA). However, this approach often results in fluctuations in serum
concentrations that can manifest clinically as inadequate pain to profound respiratory
depression.5 The use of the longest acting opioid available,6 methadone, a potent μ-receptor
agonist,6 potent N-methyl-D-aspartate (NMDA) antagonist,7 and inhibitor of serotonin and
norepinephrine reuptake in the brain8 has been recently investigated in many surgical procedures
and shown to provide superior analgesia as well as a reduction in postoperative opioid
consumption 24 to 72 hours after surgery compared to traditional short-acting opioids.9-29 After a
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single intraoperative dose of methadone 0.15-0.3mg/kg,10,11,13,14,16,18-20,22-24,26,29 serum
concentrations remain relatively stable due to its long elimination half-life of 24-36 hours.25,27
Clinical Significance
In 2003, Apfelbaum et al30 conducted a national survey, assessing patients' postoperative
pain experience and quality of acute pain management. It was estimated that approximately 80%
of patients experienced pain after surgery, with 86% of this sample describing their pain as
moderate, severe, or extreme pain despite the use of analgesics. Also, more patients experienced
pain after discharge.30 The authors concluded that although an estimated 25% of patients treated
with pain medications experienced adverse effects, almost 90% were satisfied with their pain
management; despite increased awareness and focus on improving pain after surgery. The study
showed that patients continue to experience unacceptable amounts of pain and, further efforts are
required to enhance postoperative pain experience.30
Recently, Gan et al31 surveyed a random sample of postoperative adults, n=300, to assess
patient perceptions and satisfaction with postoperative pain management. It was estimated that
approximately 86% of patients experienced pain after surgery, with 75% experiencing moderate,
severe, or extreme pain immediately after surgery, and 74% experiencing high levels of pain
after discharge despite analgesics.31 The authors determined that although there is increased
awareness and advancement in pain management, there has been little improvement in
postoperative pain experience as measured by the aforementioned survey. In both of these
surveys, most inpatients were treated with shorter-acting analgesics such as morphine,
meperidine, and hydromorphone.
Despite published clinical practice guidelines,32 recommendations for pain management
entail; establishing an acute pain service (APS), educational programs about pain and its
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management, involving patients in treatment decisions, utilizing systematic and standardized
assessment of pain, and a multimodal pain management approach using opioids. Other strategies
include novel anti-inflammatory analgesics, antiepileptic drugs, local and regional analgesia
techniques, and implementing nonpharmacological interventions. With all the recommendations
for pain management, there is still measurable poor postoperative pain experience reported by
patients.2 The use of short-acting opioids is failing to improve patients’ postoperative pain
experience. A paradigm shift utilizing novel analgesics is required to address this unmet need in
the patient's pain experience.
Poorly managed acute postoperative pain can result in alterations of psychological and
physiological functions increasing morbidity. In 2017, Gan, elucidated physiological alterations
such as increased myocardial demand, hypoventilation, pulmonary infection, reduced
gastrointestinal motility, ileus, nausea, vomiting, increased risk of urinary retention, oliguria, and
even impair immune function and wound healing.33 Psychologically, poorly controlled
postoperative pain can produce sleep impairment, anxiety, and depression.33
Acute postoperative pain can transition to the development of chronic surgical pain.
Chronic surgical pain is defined as “persistent post-surgical pain that lasts for more than 3-6
months after surgery”.1 The incidence of the development of chronic surgical pain is estimated to
occur in 10-60% of patients after standard procedures such as amputation, breast surgery,
thoracotomy, hernia repair, coronary bypass grafting, and cesarean section.1,33 A vast amount of
studies have identified that the incidence and intensity of acute postoperative pain are significant
prognostic risk factors for developing chronic pain.34-36
Unmanaged postoperative pain can negatively impair physical function, recovery, and
quality of life.33 In a prospective cohort study, n=625, of patients undergoing elective surgery, it
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was shown that patients with uncontrolled pain four days after surgery were at increased risk for
functional limitations. These limitations were defined as problems with mobility, physical
activity, self-care after surgery; poor recovery, lower scores on the global surgical recovery
index; and self-reported more subordinate levels of quality of life at six months.34 Additionally,
persistent and excessive opioid consumption can result from poorly managed postoperative pain
leading to increased risk of adverse effects and toxicity.33 In contrast, a recent cohort study
evaluating new persistent opioid use after major and minor surgery determined ongoing use of
opioids was related to behavioral disorders and not necessarily due to surgical pain.37
Poorly controlled postoperative pain has profound health economic implications. Lack of
analgesia can result in increased length of stay, time to discharge, readmission rates, and time
before ambulation.33 Delay in any of these metrics is associated with increased cost. A
retrospective analysis of patients undergoing same-day surgery revealed that 120 patients
presented for unexpected admission due to uncontrolled pain resulting in charges of $1,869 +/$4,553 per visit.38 Nationwide, according to the Institute of Medicine, the annual cost of pain in
the United States is alarming and estimated to be $560-$635 billion due to the cost of health care
and the cost of lost productivity due to pain.39
PICO Question
(P) In adult surgical patients, (I) does intraoperative administration of single-dose
methadone (C) compared to short-acting opiate therapy (O) decrease postoperative opiate
consumption for the first 24-48 hours after surgery? There are three primary objectives within
this study. First, critique and critically appraise current primary research studies involving the
use of methadone to treat acute post-surgical pain. Second, address the barriers with clinicians
and patients in preventing the implementation of evidence-based methadone use. Third, devise

10
an algorithm based on the evidence found from the prospective quality improvement project,
current literature, and guidelines recommended to anesthesia providers’ clinical practice.
METHODOLOGY
Information Sources and Search Strategy
This quality improvement project adheres to the recommendations of the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses Protocol (PRISMA-P) and was used
as a guide when selecting primary research studies.40 Utilizing a protocol in the selection of
primary research articles allows anticipation of potential problems, prevents haphazard decision
making, and may reduce replication efforts. The following electronic databases were searched:
MedLine (ProQuest), Excerpta Medica Database (EMBASE), and Cumulative Index of Nursing
and Allied Health Literature (CINHAL). Key words included: “methadone”; frequently
administered perioperative opioids such as “fentanyl”, “sufentanil”, “remifentanil”, “morphine”,
and “hydromorphone”; “postoperative analgesia”, and “pain control”. A detailed table describing
the exact keywords, subject headings, and filters applied in each database search is shown in
Table 1.
The developed PICO question: (P) In adult surgical patients (I) does intraoperative
administration of single-dose methadone (C) compared to short-acting opiate therapy (O)
decrease postoperative opiate consumption for the first 24-48 hours after surgery? The CINHAL
database yielded 71 results, the MedLine database yielded 377 results, and the EMBASE
database yielded 49 results. This resulted in a total of 497 articles from all 3 databases. After
duplicates were removed, 390 full-text articles were available for abstract screening. The steps
involving the selection and exclusion stages of the articles are represented in the flow diagram
proposed in the PRISMA statement as shown in Figure 1.
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Identification

Figure 1. PRISMA Flow Diagram

Records identified through
database searching
(n = 497)

Additional records identified
through other sources
(n = 0)

Included

Eligibility

Screening

Records after duplicates removed
(n =107)

Records screened
(n =390)

Full-text articles assessed for
eligibility
(n = 20)

Studies included in
qualitative synthesis
(n = 15)

Records excluded
(n =370)

Full-text articles
excluded, with reasons
(n = 5)
2 Incorrect patient
population
1 Incorrect Language
2 Incorrect Study Design
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Table 1. Database Search Table
Key Words

Methadone
or Dolphine

CINAHL

(Methadone
OR Dolophine
OR
"Methadone
Hydrochloride
" OR
"Hydrochlorid
e
Methadone")

MEDLINE
(Proquest)

(Methadone[
mh] OR
Dolophine[tia
b] OR
"Methadone
Hydrochloride
"[tiab] OR
"Hydrochlorid
e
Methadone"[ti
ab])

Fentanyl or
morphine or
sufentanil or
alfentanil or
remifentail
(opioids OR
opioid OR
Fentanyl OR
"Fentanyl
Citrate" OR
remifentanil OR
"remifentanil
monohydrochlor
ide" OR
"remifentanil
hydrochloride"
OR Ultiva OR
Sufentanil OR
"Sufenta" OR
"alfentanil" OR
morphine)
(opioids[tiab]
OR opioid[tiab]
OR
Fentanyl[mh]
OR "Fentanyl
Citrate"[tiab]
OR
Sublimaze[tiab]
OR
remifentanil[tiab
] OR
"remifentanil
hydrochloride"[t
iab] OR
Ultiva[tiab] OR
Sufentanil[mh]]
OR
"Sufenta"[tiab]
OR
"alfentanil"[tiab]
OR
morphine[tiab~]
OR
morphine[mh])

Postoperati
ve pain or
analgesia

Filters Applied

(postoperati §
ve OR
perioperativ
e OR
postsurgical
OR
intraoperativ
e OR "pain
postoperativ
ely") "pain
control" OR
analgesic
OR
analgesia
OR "pain
management
"
(postoperati §
ve[tiab] OR
perioperativ
e[tiab] OR
postsurgical
[tiab] OR
perioperativ
e[tiab] OR
intraoperativ
e[tiab] OR
"pain
postoperativ
e"[mh] OR
"pain
postoperativ
e"[tiab] OR
intraoperativ
e[tiab)
("pain
control"[tiab
] OR
analgesic[tia
b] OR "pain
management
"[tiab] OR
"analgesia"[t
iab]

Filters Applied:
1986-2020, Full Text,
and Source Type
Academic Journal.
Yielded 71 results.

Filters applied:
Embase only,
Human,Adults,
English, 1986-2020,
Human Filter, Free
Full Text, and Article
Type RCT. Yielded
377 results.
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EMBASE

('methadone'/e
xp OR
'dolophine'
OR
'methadone
hydrochloride'

('opiate'/exp OR
'opium' OR
'opial' OR
'opiate' OR
'opioid' OR
'fentanyl'/exp
OR
'sufentanil'/exp
OR
'morphine'/exp
OR
'remifentanil'/ex
p OR 'ultiva')

('postoperati
ve pain'/exp
OR 'pain,
postoperativ
e' OR 'post
operation
pain' OR
'postoperativ
e pain' OR
'perioperativ
e pain'/exp
OR
perioperativ
e OR
postsurgical
OR
intraoperativ
e) ('pain
control'/exp
OR
'analgesic

§

Filters applied:
EMBASE ONLY
(removed Medline
duplicates), Humans,
and Adults. Yielded
49 results.

Study Selection and Screening Method with Inclusion/Exclusion Criteria
The preliminary PICO question was utilized to screen the resulting titles and abstracts.
The investigator organized the selected articles via Endnote into a “Methadone RCT” group,
“Methadone Background” group, and “Unrelated” group. Fifteen articles were sorted into the
“Methadone RCT” group, twenty-eight articles were sorted into the “Methadone Background”
group, and the remainder was sorted into the “Unrelated” group. Using Endnote software
duplicates were removed. Full-text screening was conducted on the fifteen articles utilizing a
developed inclusion and exclusion criteria shown below in Table 2.
The inclusion criteria consisted of articles published in the English language, articles
published from 1986 to the present day, randomized single or double-blinded controlled trials,
adults between the ages of 18-99 undergoing surgery, male or female, methadone utilized in the
perioperative setting, comparison to other short-acting opioids, primary outcomes or endpoints
including postoperative opioid consumption 24-72 hours after surgery, postoperative pain scores
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measured by visual analogue scale (VAS), numerical rating scale (NRS), or verbal rating scale
(VRS), and time to first dose of analgesic after surgery. All other results were excluded. A
detailed table of the inclusion and exclusion criteria is shown in Table 2.
Fifteen studies were included in this review,9-11,13-16,18-20,22-24,26,28 of which eleven studies
used methadone in analgesic bolus doses ranging from 0.1 to 0.3 mg/kg at the beginning of the
surgical procedure,13,14,16,18-20,22-24,26,28 three studies used methadone 20 mg after anesthesia
induction,9-11 and one study used methadone 0.1 mg/kg at the end of the procedure.15 Nine
studies used methadone as the sole opioid during anesthesia, 13,16,18-20,22,24,26,28 while six studies
used methadone co-administered with other opioids in the intervention group.9-11,14,15,23 Control
groups received morphine, hydromorphone, fentanyl, sufentanil, or remifentanil. Surgical
interventions varied among the studies; therefore, the cumulative dose of opioids in control
groups also showed a wide variation.
Table 2. Inclusion and Exclusion Criteria
Inclusion
Population:
§ Adults (>18 years of age)
§ Male or Female
Type of procedure:
§ Any surgical procedure
Intervention:
§ Studies on various IV methadone doses given in
the perioperative setting to treat acute surgical
pain.
Primary outcomes:
§ Postoperative opioid consumption
§ Postoperative pain scores- measured by scales
such as VAS, NRS, or VRS.
§ Time to first analgesic- time until the first request
for analgesic by the patient.
Type of study:
§ English language
§ Randomized controlled trials
§ Single or double-blinded
§ Publication date 1986-Present

Exclusion
Population:
§ Children (<18 years of age)
Type of procedure:
§ Methadone used to treat noncancer chronic pain or cancerrelated pain.
Intervention:
§ Methadone was not given
during the perioperative
period.
Outcomes:
§ Anything other than
postoperative opioid
consumption, postoperative
pain scores, and time to the
first analgesic.
Type of study:
§ Non-English
§ Systematic reviews
§ Meta-analysis
§ Questionnaire
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Collection, Analysis, and Data Items
The Johns Hopkins Evidence-Based Practice Evidence Level and Quality Guide was
utilized to systematically evaluate and appraise the selected studies. The Johns Hopkins
Evidence Level and Quality Guide ranks evidence on three different levels; level I consisting of
experimental studies, RCT, systematic review of RCT with or without meta-analysis; level II
consisting of quasi-experimental studies with or without meta-analysis or systematic review
involving both RCT and quasi-experimental; level II consisting of non-experimental studies;
level IV consisting of expert opinion by respected authorities or committees; and level V
consisting of empirical non-research evidence such as case reports or literature reviews.41
Each evidence level is attached to a quality guide. For evidence levels I-III, quality is
assigned as high, good, or low.41 High quality (A) is evident if a sufficient sample size was
selected for the study design, adequate control was present, the definitive conclusion stated, and
consistent recommendations could be made. Good quality (B) is evident if a sufficient sample
size was selected for the study, some control, fairly definitive conclusions stated, and reasonably
consistent recommendations could be made.41 Lastly, low quality (C) is evident if insufficient
sample size is selected, inconsistent results are present, and if conclusions could not be made.41
RESULTS
Postoperative Opioid Consumption, Pain Intensity, Patient Satisfaction, & Incidence of
Opioid-Related Side Effect
Mercadante et al conducted a randomized controlled trial in 2020 on the quality of
postoperative analgesia in adults receiving either methadone or morphine during the
perioperative period.22 The study sample included sixty women between the ages of 18-65, with
similar patient characteristics such as age, weight, comorbidities, and American Society of
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Anesthesiologists (ASA) physical status between I-II undergoing open hystero-salpingectomy
due to gynecological cancer under identical general anesthesia technique and management.22
Patients in the experimental group were allocated to receive 0.15mg/kg methadone intravenous
bolus preoperatively followed by methadone infusion at 12mg/day following surgery (n=28)
while the control group was allocated to receive 0.15mg/kg morphine intravenous preoperatively
followed by morphine infusion at doses of 12mg/day following surgery (n=32).22 The
investigators collected pain intensity data utilizing an 11-point numerical rating scale (NRS) at
different time intervals on the operative day and second postoperative day, pain intensity
differences (PID), time-weighted summed pain intensity difference duration over 48 hours
(SPID48), and total opioid consumption.22 The investigators found opioid consumption was
significantly lower in the methadone group on operative day, P =0.002, and 24 hours after
surgery, P <0.0005 compared to the control group.22 Also, the difference was significant for pain
intensity difference (PID) at the last measurements on the second day, P =0.005, and lower
values of summed pain intensity differences over 48 hours (SPID48) were found in the
methadone group, although the difference was not significantly different between the two
groups.22
In 2020, Tognoli et al performed a randomized controlled trial evaluating methadone,
ketamine, and morphine for postoperative analgesia.23 The sample population included 96 male
and female adults, ASA physical status I-II, between the ages of 18-75 with no significant
difference between patient characteristics scheduled for open laparotomy for anterior resection of
the colon between 2010 to 2012.23 Patients were allocated to receive either an intraoperative
infusion of saline and postoperative morphine patient-controlled analgesia (PCA) (n=24),
intraoperative ketamine infusion and postoperative morphine PCA (n=25), intraoperative
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infusion of saline and methadone PCA (n=23), or intraoperative ketamine infusion and
postoperative methadone PCA (n=24).23 Opioid analgesia began 45 min before the expected end
of surgery; a loading dose of 0.2 mg/kg of the opioid, morphine, or methadone according to the
patients’ group, was administered.23 Ketamine administration was intended to prevent ketamineassociated side effects, mainly, excessive sedation near patient awakening, administration was as
follows: just after induction of anesthesia, an infusion of ketamine was started at 5mcg/kg/min
for 10 min, followed by an infusion of 2.5mcg/kg/min for 20 min, and then an infusion of
2mcg/kg/min until 10 min after the intra-operative loading dose of opioid, towards the end of
surgery.23 Methadone and morphine were administered by a PCA pump set to deliver 1 mg as an
intravenous bolus with a lock-out interval of 6 min, without limits or basal infusion.23 The
investigators collected the extent of hyperalgesia utilizing von Frey hair stimulation test lateral to
surgical incision performed on the first and second postoperative day, static and dynamic pain
numeric rating scores (NRS), the incidence of opioid-related side effects, and opioid
consumption.23 Tognoli et al found while opioid consumption was attenuated in methadonetreated groups, the results were not statistically significant, P= 0.32, peri-incisional hyperalgesia
was 8.4 cm (95% confidence interval, 1.5 to 15.41) lower in the methadone treatment group
compared with the control group at 24 h after surgery, P =0.02, and groups treated with
methadone had significantly lower pain during rest and movement, as measured with a NRS at
24 hours, and at 48 hours, only the movement NRS was significantly lower.23 Additionally, no
significant differences in mobilization, peristalsis reactivation, and incidence of postoperative
nausea and vomiting at 24 to 48 postoperative hours in patients treated with methadone were
noted.23
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Moro et al conducted a randomized controlled trial in 2019 on the effect of methadone on
postoperative quality of recovery in patients undergoing laparoscopic cholecystectomy at an
academic medical center in Sao Paulo, Bazil.20 The sample population included 70 adults both
male and female, ages 18-65, ASA physical status I-II, and with similar patient characteristics
undergoing elective laparoscopic cholecystectomy under identical general anesthesia technique
and management.20 Patients in the experimental group were allocated to receive 0.1mg/kg
methadone on anesthesia induction (n=35) and the control group was allocated to receive
0.1mg/kg morphine on anesthesia induction (n=35) for intraoperative analgesia.20
Postoperatively, whenever patients in both groups judged their analgesia to be insufficient (pain
score > 3), tramadol 100 mg was administered intravenously.20 The investigators collected the
Quality of Recovery 40 (QoR-40) questionnaire which involved assessment of emotional status,
physical comfort, psychological support, physical independence, and pain preoperatively and
postoperative day 1, pain intensity at multiple intervals utilizing NRS, the incidence of opioidrelated side effects, and total opioid and tramadol consumption.20 Moro et al found opioid
consumption while in the PACU was higher in the morphine group, P < 0.02.20 The investigation
also found pain scores, at rest and with coughing, assessed using a numerical rating scale upon
PACU arrival and every 15 min until PACU discharge were similar between groups.20
Additionally, no differences observed in the total or individual QoR-40 dimension scores
between methadone and morphine treated patients and the incidence of postoperative nausea and
vomiting (PONV) in the PACU and 24-48 hours after surgery were not statistically significant, P
<0.02, and P =0.78, respectively.20
The postoperative analgesic effects of intraoperative methadone were investigated in a
randomized controlled trial by Komen et al in 2019.19 The study sample consisted of 60 male and
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female adults, ages 18-65, ASA I-III, with similar characteristics undergoing same-day surgical
procedures under identical general anesthesia technique.19 Patients in the experimental group
were allocated to receive 0.1mg/kg methadone on anesthesia induction (n=18) or 0.15mg/kg
methadone on anesthesia induction (n=21) and patients in the control group were allocated to
receive short-duration opioids, either fentanyl or sufentanil, on anesthesia induction (n=21) at
variable dosages based anesthesia provider’s discretion.19 Patients receiving methadone at
induction received no additional opioids during the surgical procedure and those randomized to
receive short-duration opioids could receive additional doses of fentanyl or sufentanil during
maintenance at the provider’s discretion.19 For all groups, postoperative pain management
included fentanyl or hydromorphone with dosing-based pain assessment in PACU and oral
analgesics (oxycodone, hydrocodone, or acetaminophen) instituted after discharge from PACU
and until discharge from hospital.19 The investigators collected NIH PROMIS-29 profile, pain
intensity at multiple intervals utilizing NRS and modified observer’s assessment of alertness and
sedation, total opioid consumption in PACU, total opioid consumption day of surgery, total 30day post-discharge opioid, and incidence of opioid-related side effects.19 The study found total
opioid consumption in the PACU was significantly less compared with controls, 9.3 mg, 1.3–
11.0, in subjects receiving 0.15 mg/kg methadone, P < .001; total in-hospital nonmethadone
opioid use after short-duration opioid, 0.1 mg/kg methadone, and 0.15 mg/kg methadone was
35.3 mg morphine equivalents, P < .001 for both versus control; and 30 days after discharge
patients who received methadone 0.15 mg/kg used fewer opioid pills than controls, P < .0001.19
Komen et al found in-hospital pain scores were not different between groups and 30 days after
discharge, patients who received methadone had less pain at rest, P = 0.02, and found the
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percentage of patients receiving PACU ondansetron, PACU diphenhydramine, or any PACU
antiemetic in the control and methadone groups was not different, P = 0.60.19
In 2019, Bastian et al conducted a randomized controlled trial on the effects of a
preoperative single dose of methadone for moderate-to-severely painful surgery reducing
postoperative morphine consumption.18 The study population included 130 male and female
adults, ages 18-75, ASA I-III, with no significant difference in characteristics undergoing
thoracoabdominal, orthopedic, breast, or vascular surgeries under identical general anesthesia
technique at a regional 372-bed hospital.18 Patients in the experimental group were allocated to
receive methadone 0.2mg/kg on anesthesia induction (n=73) and the control group was allocated
to receive fentanyl 3mcg/kg on anesthesia induction (n=57).18 Intraoperatively, in both groups,
signs of pain such as hypertension or tachycardia were treated with fentanyl 50-100mcg bolus at
the discretion of the anesthesia provider.18 Postoperatively, both groups received morphine PCA,
initiated in PACU, with identical settings: 1mg bolus, 6-minute lockout, and no basal infusion.18
The investigators collected static and dynamic pain intensity at multiple intervals measured by
NRS, postoperative analgesia patient satisfaction scores measured by a survey, opioid
consumption in PACU, opioid consumption on postoperative days 1-3, intraoperative fentanyl
requirements, and preoperative as well as postoperative QTc.18 Bastian et al found median
cumulative morphine consumption was significantly lower in patients receiving a single dose of
methadone, in the PACU, P <0.01, and during the first 72 hours after surgery, P <0.05 for all
days.18 Also, median pain scores at rest and in motion, were also similar in both groups during
follow-up on postoperative days 1-3.18 The investigators also found patient satisfaction were also
similar in both groups 95.7% vs. 89.3% of patients were satisfied in the study and control group
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during follow-up on postoperative days 1-3 and no significant difference in preoperative and
postoperative QTc time between methadone and control groups, P =0.755.18
Machado et al performed a randomized controlled trial on the intraoperative use of
methadone improving control of postoperative pain 2018.16 The study sample included 32 male
and female adults, ages 32-59, all ASA II, with no significant difference in patient characteristics
undergoing open bariatric surgery under identical general anesthesia technique.16 Patients
randomized to the experimental group were allocated to receive methadone 0.15mg/kg IBW
given on anesthesia induction and methadone 0.05mg/kg IBW every 10 minutes if necessary due
to signs of pain intraoperatively (n=16) and patients in the control group were allocated to
receive fentanyl 6mcg/kg IBW on anesthesia induction and fentanyl 2mcg/kg IBW every 10
minutes if necessary due to signs of pain intraoperatively (n=16).16 Both groups received incision
infiltration with 20mL of 0.375% ropivacaine and morphine 3mg at surgery conclusion.
Postoperatively, all patients in both groups received morphine PCA initiated in PACU with
identical settings: 2mg bolus, 5 minutes lockout, and no basal infusion. Data collection included
pain intensity at multiple intervals measured by visual analogue scale (VAS), total postoperative
opioid consumption 72 hours after surgery, pain management satisfaction scale, and 3-month
evaluation of spontaneous or evoked pain in incision with manual palpation.16 The investigators
found postoperative morphine consumption was significantly higher for patients receiving
fentanyl than methadone during the postoperative period at 2 hours, mean difference (MD) 6.4
mg; 95% CI 3.1–9.6; P <0.001, 2–6 hours MD 11.4 mg; 95% CI 6.5–16.2; P <0.001, 6–24 hours
MD 10.4 mg; 95% CI 5.0–15.7; P <0.001, and 24–48 hours MD 14.5 mg; 95% CI 3.9–25.1; P
=0.01.16 The investigation also found pain scores at rest were higher in the fentanyl group at 2
hours, P <0.001, 6 hours, P <0.001, and 24 hours, P =0.001 than the methadone group; pain
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scores at coughing were higher in the fentanyl group at 2 hours, P <0.001, 6 hours, P <0.001, 24
hours, P <0.001, and 72 hours, P=0.02; and no difference was observed at 48 hours between the
two groups.16 Additionally, the median patient satisfaction score was lower for the fentanyl
group compared with the methadone group at 24 hours, P =0.004, 48 hours, P =0.015, and 72
hours, P =0.015, postoperatively.16
In 2018, Carvalho et al conducted a randomized controlled trial comparing postoperative
analgesia with methadone and morphine.15 The study population included 100 male and female
adults, ages 18-75, ASA III-IV, and with no significant difference in patient characteristics such
as age, weight, height, and duration of surgery undergoing coronary artery bypass grafting
without cardiopulmonary bypass under identical general anesthesia technique. Patients in the
experimental group were allocated to receive methadone 0.1mg/kg (n=50) and patients in the
control group were allocated to receive morphine 0.1mg/kg (n=50), both to be administered after
the procedure.15 Additionally, both groups received sufentanil 0.5mcg/kg on induction of
anesthesia and intraoperative sufentanil infusion 0.25mcg/kg/hr. Postoperatively, patients in both
groups were allowed to receive morphine 0.03mg/kg for complaints of moderate to severe pain
with a limit of 0.1mg/kg in 4 hours.15 The investigators collected pain intensity measured by
NRS at multiple intervals, time to the first analgesic requested by the patient, total postoperative
opioid consumption, intraoperative sufentanil requirements, and incidence of opioid-related side
effects.15 The study found the methadone group required less postoperative morphine, 29%, than
the morphine group, 43%, P = 0.002.15 Additionally, methadone showed 22% higher efficacy
than morphine as it yielded a number-needed-to-treat score of 6 and a number-needed-to-harm
score of 16, the methadone group showed a mean score of 1.9 ± 2.2 according to the numerical
pain scale at 24 h after surgery, whereas as the morphine group showed a mean score of 2.9 ±
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2.6, P = 0.029, conversely, the time to first analgesic request in the postoperative period was
145.9 ± 178.5 min in the methadone group, and 269.4 ± 252.9 in the morphine group, P =
0.005.15 No significant difference in adverse effects, P =0.52, nausea, P =0.457, and vomiting P
=0.248 36 hours after surgery were observed.15
Murphy et al performed a randomized controlled trial in 2017 evaluating the
effectiveness and safety of intraoperative methadone.14 The sample population included 115
male and female adults, ages 18-80, ASA II-III, with similar patient characteristics such as sex,
age, weight, height, ASA status, and no significant difference in comorbidities such as smoking
and drinking history, coronary artery disease, myocardial infarction, congestive heart failure,
atrial fibrillation, hypertension, chronic obstructive pulmonary disease (COPD), sleep apnea,
thyroid disease, diabetes, stroke, and peripheral vascular disease undergoing elective posterior
lumbar, thoracic, or lumbothoraric spinal fusion surgery under identical general anesthesia
technique.14 The patients in the experimental group were allocated to receive methadone
0.2mg/kg on anesthesia induction and placebo, saline solution, at surgical closure (n=62), and
patients in the control group were allocated to receive placebo, saline solution, on anesthesia
induction and hydromorphone 2mg at surgical closure (n=53).14 Postoperatively, all patients in
both groups were allowed to receive hydromorphone 0.25mg for moderate pain and
hydromorphone 0.5mg for severe pain in PACU until pain scores less than or equal to 3 on NRS
0 to 10, hydromorphone PCA was then initiated in all patients with identical settings for pain
control POD 1 to 3, and oral opioid therapy consisting of hydrocodone 10mg and acetaminophen
325mg as needed was initiated on POD 2 with discontinuation of hydromorphone PCA on POD
3.14 The investigators collected pain intensity measured by VAS at multiple intervals, total
postoperative opioid consumption in PACU, pain management satisfaction, total postoperative
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opioid consumption 3 days after surgery, and incidence of opioid-related side effects.14 The
study found median hydromorphone use was reduced in the methadone group not only on
postoperative day (POD) 1, 4.56 vs. 9.90mg, but also on postoperative days 2, 0.60 vs. 3.15mg,
and 3, 0 vs. 0.4mg, all P < 0.001; the total amount of hydromorphone patient-controlled
analgesia self-administered during the first three postoperative days was also significantly less in
the methadone group; fewer oral opioid tablets were needed in the methadone group on POD 3
when patients were being transitioned from PCA hydromorphone to oral opioid pills; and total
oral opioid requirements were less in this group.14 Additionally, median VAS pain scores
reported by patients at rest, with coughing, and with movement were lower in the methadone
group compared to the hydromorphone group at all assessment times, except pain at rest in the
afternoons of PODs 1, 2, and 3 and pain with coughing in the afternoons of PODs 1 and 3, P
=0.001 to <0.0001.14 Overall satisfaction with pain management, on a 0 to 100 VAS, was higher
in the methadone group from PACU admission through the morning of POD 3, all P = 0.001 to <
0.0001.14 Study groups did not differ in the incidences of nausea, vomiting, requirements for the
treatment of nausea or vomiting, itching, hypoventilation, or hypoxemic events from PACU
admission through the afternoon of POD 3, all P >0.05.14
In 2015, Murphy et al conducted a randomized controlled trial to evaluate intraoperative
methadone for the prevention of postoperative pain.13 The sample population included 156
female and male adults, ages 50-70, ASA III-IV, with similar patient characteristics such as sex,
weight, height, and ASA class undergoing elective cardiac surgery with cardiopulmonary bypass
performed under identical general anesthesia technique 13 No significant differences were noted
in presence of comorbidities such as smoking and drinking history, myocardial infarction,
congestive heart failure, atrial fibrillation, hypertension, COPD, sleep apnea, thyroid disease,
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diabetes, stroke, or peripheral vascular disease.13 Patients in the experimental group were
allocated to receive methadone 0.3mg/kg intraoperatively (n=77) and patients in the control
group were allocated to receive fentanyl 12mcg/kg intraoperatively (n=79).13 At anesthesia
induction, one half of the study opioid (either 0.15mg/kg of methadone or 6 μg/kg of fentanyl)
was administered via an infusion pump over 5min and the remainder of the study opioid
(0.15mg/kg of methadone or 6 μg/kg of fentanyl) was infused over the next 2 hours.13
Postoperatively, morphine 2mg was administered to patients if the pain of more than mild
severity was noted, with additional doses given until the patient was comfortable, verbal pain
score <3 on a 0 to 10 scale.13 Patients were transitioned to oral pain medication near the time of
transfer to the surgical wards. Oral pain medication consisted of one 10-mg hydrocodone, 325mg acetaminophen tablet for mild pain, and two tablets for moderate pain.13 The investigators
collected intraoperative hemodynamics, pain intensity measured by NRS at multiple intervals,
pain management satisfaction, and daily and total opioid consumption during hospitalization.13
The study found postoperative morphine requirements during the first 24h were reduced from a
median of 10mg in the fentanyl group to 6mg in the methadone group, the median difference
[99% CI], −4 [−8 to −2] mg; P < 0.001, and total morphine use over the first 72h was less in the
methadone group, 4 to 14 mg, than it was in the fentanyl group, 8 to 28 mg, P < 0.001.13
Additionally, pain scores at rest were significantly less in the methadone group than they were in
the fentanyl group at 2, 4, 8, 12, 24, 48, and 72 hours after tracheal extubation, P < 0.001,
overall satisfaction with pain management, measured on a 101-point visual analog scale, was
higher in the methadone group than in the fentanyl group, all P < 0.001 to 0.006 at all
measurement times except at 12hours, P = 0.025.13
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Udelsmann et al performed a randomized controlled trial to investigate the repercussion
in postoperative analgesia in patients administered methadone or morphine.11 The study
population included 55 male and female adults, ages 18-80, ASA III-IV, and with similar patient
characteristics such as age, sex, ASA, and BMI undergoing cardiac surgery under identical
general anesthesia technique.11 Patients in the experimental group were allocated to receive
methadone 20mg after anesthesia induction (n=18) and patients in the control groups were
allocated to receive morphine 20mg after anesthesia induction (n=10) or saline solution (n=18).11
All patients in the three groups received sufentanil 0.1mcg/kg on induction of anesthesia and
intraoperative sufentanil infusion 0.01mcg/kg/min.11 Postoperatively, in the ICU after
extubation, all patients in all groups were allowed to receive morphine 0.03mg/kg whenever
necessary based on pain VAS.11 The investigators collected time required until the
administration of a requested analgesic, extent of analgesia 24 hours after surgery, total analgesic
consumption at 48 postoperative hours, and incidence of opioid-related side effects.11 Udelsmann
et al found the first dose of analgesic in the methadone group was required after a long time, P =
0.0261, the number of patients who needed analgesics was significantly lower in the methadone
group, P= 0.025, and the number of doses of analgesic in 24 hours in the control group was
significantly greater than in methadone treated patients, P < 0.001.11 Furthermore, the quality of
analgesia after 24 hours according to the patient was significantly better in the methadone group,
P < 0.01.11 The investigation also found that patients in the methadone group had a significantly
lower incidence of nausea and or vomiting compared to the control group, P = 0.013.11
In 2011, Gottschalk et al studied the use of intraoperative methadone to improve
postoperative pain.10 The study sample included 29 male and female adults, ages 32-70, ASA III, and with no significant difference in patient characteristics such as age, weight, height, BMI,
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and or preoperative opioid use undergoing multilevel thoracolumbar spine surgery performed
under identical general anesthesia technique.10 Patients in the experimental group were allocated
to receive methadone 0.2mg/kg before intubation (n=13) and patients in the control group were
allocated to receive a loading dose of sufentanil 0.75mcg/kg before incision followed by
sufentanil infusion of 0.25mcg/kg/hr (n=16).10 In all patients in both groups, signs of inadequate
anesthesia such as hypertension, tachycardia, or patient movement, was treated with a sufentanil
bolus of 0.1 mcg/kg IV every 2.5 minutes at the discretion of the attending anesthesiologist.10
Postoperatively, all patients in both groups received PCA for analgesia, however, the choice of
agent either fentanyl, hydromorphone, or morphine, was at the discretion of the surgeon.10 All
opioid consumption was converted to morphine equivalents by the authors to allow accurate
analysis. Data collection included pain intensity measured by VAS at multiple intervals,
intraoperative sufentanil requirements, opioid consumption 24-72 hours after surgery, and
incidence of opioid-related side effects.10 The authors found seven patients in both groups
received additional sufentanil boluses with no difference in the total amount of sufentanil,
methadone reduced postoperative opioid requirement by approximately 50% at 48 hours,
sufentanil versus methadone group, median 63 mg vs. 25 mg morphine equivalents, P =0.023
and 72 hours, 34 mg vs 15 mg morphine equivalents, P =0.024 after surgery.10 Additionally, pain
scores were lower by approximately 50% in the methadone treated patients at 48 hours after
surgery, sufentanil versus methadone group, 4.8 +/- 2.4 vs 2.8 +/- 2.0, P = 0.026.10 The incidence
of nausea, vomiting, arrhythmia, hypoxemia, and respiratory depression were comparable
between methadone and the control group, all P >0.05.10
Simoni et al conducted a randomized controlled trial in 2009 to evaluate the efficacy of
intraoperative methadone and clonidine pain control in the immediate postoperative period after
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the use of intraoperative remifentanil infusion.9 The study population included 126 male and
female adults, ages 18-65, ASA I-II, and with no significant difference in patient characteristics
such as age, sex, weight, height, and IBW undergoing video laparoscopic surgery under identical
total intravenous anesthesia technique. Anesthesia was induced in all patients with targetcontrolled infusion (TCI) of remifentanil at a target dose of 6.0mcg/mL and propofol at a target
dose of 4.0mcg/mL.9 Patients in the experimental groups were allocated to receive methadone
0.1mg/kg (n=42) or clonidine 2mcg/kg (n=42) after induction of anesthesia and patients assigned
to the control group received saline solution (n=42) after anesthesia induction.9 In the PACU,
intravenous tramadol, 1.5 mg/kg, was the rescue analgesic if the patient reported pain.9 Data
collected included total consumption of intraoperative remifentanil and propofol, pain intensity
at multiple intervals, total opioid consumption 24 hours after surgery, and incidence of opioidrelated side effects.9 The investigators found mean remifentanil consumption was significantly
lower in the methadone and clonidine groups than in the placebo group; however, a significant
difference between the methadone and clonidine groups was not observed, P < 0.05.9
Additionally, the incidence of pain in the methadone group was significantly lower than in the
clonidine and placebo groups, P < 0.02.9 The incidence of nausea, vomiting, and respiratory
depression were not statistically significant among the methadone group, clonidine group, and
control group, P >0.05.9
In 1992, Chui et al compared postoperative analgesia after perioperative administration of
methadone versus morphine.24 The study sample included 30 female adults, ages greater than 18,
ASA I-II, and with no significant difference in patient characteristics such as age, weight, ASA
class, or comorbidities undergoing abdominal hysterectomy under identical general anesthesia
technique.24 Patients were allocated to receive either methadone 0.25mg/kg on induction of
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anesthesia with 3-4.5mg increments in PACU if the patient reported pain (n=15) or morphine
0.25mg/kg on anesthesia induction with 3-4.5mg increments in PACU if the patient reported
pain (n=15).24 Postoperatively, patients were prescribed morphine 7.5 mg IM two-hourly ondemand in the ward.24 Data collection included pain intensity measured by NRS at multiple
intervals and opioid consumption 48 hours after surgery.24 The authors established that 24 hours
after surgery patients in the methadone group requested fewer doses of supplementary opioids
than those in the morphine group, P < 0.001, and ten out of fifteen patients, 67%, in the
methadone group did not require any further parenteral opioids while all patients in the morphine
group required at least two further doses of morphine.24 Additionally, pain scores in the
methadone group declined and the scores remained low for the 48 hour study period, the
morphine group of patients had a higher total pain score for the 48 hour study period, P < 0.001,
despite having received more supplementary doses of morphine, and in the follow-up interview,
patients in the methadone group gave lower scores for both the worst pain and the overall pain
that they experienced in the postoperative period, P < 0.001.24
Gourlay et al performed a randomized controlled trial comparing the efficacy of
methadone and morphine in postoperative pain control.26 The study sample included 20 male and
female adults, ages 30-58, ASA I-II, and with no significant difference in patient characteristics
such as age, weight, sex, and ASA class undergoing upper abdominal surgery performed under
identical general anesthesia technique.26 Patients were allocated to receive either methadone
20mg on induction of anesthesia with 5mg supplemental doses in PACU or ward (n=10) or
morphine 20mg on induction of anesthesia with 5mg supplemental doses in PACU or ward
(n=10). Data collection included pain intensity measured by VAS at multiple intervals,
intraoperative opioid consumption, postoperative opioid consumptions, and time until the first
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analgesic request.26 The investigators found no significant difference between the mean amount
of supplementary methadone (8 +/- 6.3 mg) and morphine (9 +/- 9 mg) required in PACU to
provide initial pain control; the time from initial pain control to the first supplementary dose in
the surgical ward was significantly different, P <0.01, in the methadone group, 20.7 +/- 20.2
hours, when compared to the morphine group. 6.2 +/- 3.0 hours, and patients required
significantly less, P <0.001, methadone than morphine in the surgical ward to provide adequate
pain relief throughout 60 hours after surgery.26 Additionally, there was no significant difference
in visual analogue pain scores between the methadone and morphine groups on postoperative
days 1 and 2, suggesting the quality of pain relief was similar for both treatment groups.26
In 1991, Richlin et al conducted a randomized controlled trial evaluating postoperative
pain control with methadone following surgery.28 The study population included 40 female
adults, age greater than 18, ASA I-II, and with no significant difference in patient characteristics
such as age, sex, weight, or ASA class undergoing abdominal hysterectomy or myomectomy
under identical general anesthesia technique. Patients were allocated to receive either methadone
on induction of anesthesia with subsequent dosing in the PACU and surgical ward (n=20) or
morphine on induction of anesthesia with subsequent dosing in the PACU and surgical ward
(n=20).28 Data collected included pain intensity measured by VAS at multiple intervals,
intraoperative opioid consumption and postoperative opioid consumption 72 hours after
surgery.28 Richlin et al found patients required less methadone than morphine in the recovery
room and requested less methadone than morphine for pain relief on the wards, 4.5 +/- 4.2 mg vs
42.3 +/- 14.3 mg, P <0.01, and analgesic requirements reduced by 60% in the methadone group
compared to the morphine group, 28 Additionally, patients in the methadone group reported
lower pain intensity by VAS 1.9 +/- 0.3 vs 3.4 +/- 0.6, P <0.01.28
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A comprehensive evaluation table was developed to summarize and categorize the
selected studies see Table 3. Each study was assigned an evidence level and quality rating based
on the Johns Hopkins Evidence-Based Practice Evidence Level and Quality Guide tool. The
information obtained and evaluated from each study included: (1) study design and sample size,
(2) type of surgery, (3) methadone dose and timing, (4) other intraoperative analgesic utilized,
(5) postoperative analgesia regimen, and (6) postoperative consumption of opioids or analgesics.

Table 3. Studies Included in the Literature Review
Author
(Year) &
Level of
Evidence/
Quality
Rating

Study
Design &
Sample

Type of
Surgery

Methadone
Dose &
Timing

Control &
Other
Intraoperative
Analgesic Used

Postoperat
ive
Analgesia
Plan

Postoperative
Opioid/Analgesic
Consumption

Mercadante
et al.22 (2020)

Doubleblinded RCT.
60 adult
females ASA
I-III.

Open
hysteronsalpingect
omy for
gynecolog
ical
cancer.

Open
laparotom
y for
rectal
surgery

Morphine group,
n=32, received
0.15mg/kg of
morphine
preoperatively
followed by
infusion of
12mg/day started
in PACU.
Additional doses
of 3mg morphine
given for
breakthrough
pain.
Placebo and
morphine group
(0-Mo), n=24 &
ketamine and
morphine group
(K-Mo), n=25. In
both groups,
morphine
0.2mg/kg bolus
given after
anesthesia
induction and
morphine PCA
started in PACU.
Ketamine infusion

In both
groups,
patients
received
their
assigned
opioid
infusion
postoperativ
ely. In both
groups, IV
paracetamol
started
POD1.
Methadone
groups
received
methadone
PCA.
Morphine
groups
received
morphine
PCA. PCA
settings
identical.
Rescue
analgesia:
2mg of

Opioid consumption was
significantly lower in the
methadone group;
operative day, P=0.002
and second day,
P<0.0005.

Doubleblinded RCT.
96 adults
ASA I-II.

Methadone
group, n=28,
received
0.15mg/kg bolus
preoperatively
followed by
infusion of
12mg/day started
in PACU.
Additional doses
of 3mg
methadone given
for breakthrough
pain.
Placebo and
methadone group
(0-Me), n=23 &
ketamine and
methadone group
(K-Me), n=24. In
both groups,
methadone
0.2mg/kg bolus
given after
anesthesia
induction and
methadone PCA
started in PACU.
Ketamine

Level I
Quality A

Tognoli et
al.23 (2020)
Level I
Quality A

Postoperative opioid
requirements were not
significantly different
between the groups
using
the same opioid [0-Mo
49mg (23 to 157) vs. KMo 67mg
(21 to 137) 6, P=0.12; 0Me 42.5 mg (17 to 92)
vs. K-Me
32mg (19 to 97), data
shown as median (minmax),
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Moro et al.20
(2019)
Level I
Quality A

Komen et
al.19 (2019)
Level I
Quality A

Bastian et
al.18 (2019)
Level I
Quality A

Doubleblinded RCT.
70 adults
ASA I-II

Laparosco
pic
cholecyste
ctomy

Doubleblinded RCT
dose
escalation
protocol. 60
adults ASA IIII

Laparosco
pic
ambulator
y surgical
procedure
s

Doubleblinded RCT.
130 adults
ASA I-III

Thoracoabdominal
, including
laparotom
y,
laparosco
py, breast,
orthopedic

infusion only
used
intraoperatively
with doses
identical to
control.

only used
intraoperatively
with doses
identical
methadone group.

methadone
or morphine
according to
group.

P=0.32. However, less
methadone was required
in methadone-treated
patients compared to
morphine-treated
patients.

Methadone
group, n=35
received
0.1mg/kg
methadone on
anesthesia
induction.
Anesthesia
maintenance
with propofol
and remifentanil
infusion. All
patients received
dexamethasone
8mg, ketoprofen
100mg, and
dipyrone 1g
intraoperatively
Methadone
0.1mg/kg group,
n=18, received
0.1mg/kg
methadone on
anesthesia
induction &
methadone
0.15mg/kg
group, n=21,
received 0.15mg
methadone on
anesthesia
induction.
Additional short
acting opioid
could be given
for pain if
necessary.

Morphine group,
n=35 received
0.1mg/kg
morphine on
anesthesia
induction.
Anesthesia
maintenance with
propofol and
remifentanil
infusion All
patients received
dexamethasone
8mg, ketoprofen
100mg, and
dipyrone 1g
intraoperatively

Postoperativ
ely, IV
tramadol
100mg
based on
pain
assessment

Opioid consumption
while in the PACU was
higher in morphine
group (P< 0.02)

Control group,
n=21 received
fentanyl,
sufentanil, or
hydromorphone at
variable dosing.

Morphine equivalents
day of surgery were
35.3mg control group,
7.1mg in 0.1mg/kg
methadone group
(P<0.0001), and 3.3mg/
kg in 0.15mg/ kg
methadone group
(P<0.0001). In the 30
days after discharge,
patients who received
methadone 0.15 mg/kg
used fewer opioid pills
than controls (P <
.0001).

Methadone
group, n=73
received
0.2mg/kg
methadone on
anesthesia
induction

Fentanyl group,
n=57 received
0.003mg/kg on
anesthesia
induction. Both
groups could
receive additional
fentanyl due to

For all
groups,
fentanyl or
hydromorph
one with
dosingbased pain
assessment
in PACU.
Oral
analgesics
(oxycodone,
hydrocodon
e, or APAP)
instituted
after
discharge
from PACU
and until
discharge
from
hospital.
Both groups
received
morphine
PCA with
identical
settings in
PACU

Median cumulative
morphine consumption
was significantly lower
in patients receiving a
single dose of
methadone, in the PACU
(0 mg vs. 7 mg of
morphine, P<0.01) and
during the first 72 hours
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, and
vascular.

Machado et
al.16 (2018)
Level I
Quality A

Carvalho et
al.15 (2018)
Level I
Quality A

Murphy et
al.14 (2017)
Level I
Quality A

inadequate
anesthesia

Doubleblinded RCT.
32 adults
ASA II

Open
bariatric
surgery

Methadone
group, n=16,
consisting of
methadone
0.15mg/kg IBW
given on
induction of
anesthesia and
methadone
0.05mg/kg IBW
every 10 minutes
if necessary due
to pain

Doubleblinded RCT.
100 adults
ASA III-IV

Cardiac
surgery
without
CPB

Methadone
group, n=50,
received
0.1mg/kg
methadone at
conclusion of
surgery.

Doubleblinded RCT.
120 adults
ASA II-III

Complex
spine
surgery

Methadone
group, n=62,
received
0.2mg/kg
methadone on
anesthesia
induction.

Fentanyl group,
n=16, consisting
of fentanyl
6mcg/kg IBW
given on
induction of
anesthesia and
fentanyl 2mcg/kg
IBW every 10
minutes if
necessary due to
pain. Both groups
received
multimodal
analgesia with
dexamethasone
4mg, ketoprofen
100mg, dipyrone
2mg, incision
infiltration with
20mL of 0.375%
ropivacaine, and
morphine 3 mg at
surgery
completion.
Morphine group,
n=50, received
0.1mg/kg
morphine at
conclusion of
surgery. Both
groups received
identical doses of
sufentanil for
anesthesia
induction and
maintenance.
Hydromorphone
group, n=53,
received 2mg
hydromorphone
on surgical
closure.
Both groups also
received
preoperative
gabapentin 600mg
and IV APAP 1g
30 min before

Both groups
received
identical
morphine
PCA for
postoperativ
e analgesia

after surgery (19 mg vs.
35 mg of morphine,
P<0.05 for all days).
Fentanyl consumption
during surgery was
comparable among
groups.
Postoperative morphine
consumption was
significantly higher for
patients receiving
fentanyl than methadone
during the postoperative
period at 2 hours
(P<0.001), 2–6 hours
(P<0.001), 6–24 hours
(P<0.001 1), and 24–48
hours (P=0.01).

Both groups
allowed to
receive
0.03mg/kg
morphine in
ICU based
on pain
assessment

In the first 36 h, 43% of
the patients in the
morphine group required
analgesics, compared to
29% in the methadone
group (P=0.002). Time
to first request for
analgesics was longer in
the methadone group

Both groups
received
hydromorph
one 0.25mg
for moderate
pain and
0.5mg for
severe pain
until pain
scores less
than or
equal to 3

Median hydromorphone
use was reduced in the
methadone group not
only on postoperative
day 1 (4.56 vs. 9.90mg)
but also on postoperative
days 2 (0.60 vs. 3.15mg)
and 3 (0 vs. 0.4mg; all P
< 0.001). Fewer oral
opioid tablets were
needed in the methadone
group on POD 3 when
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conclusion of
surgery.
Anesthesia
maintenance with
propofol &
remifentanil
infusions.

Murphy et
al.13 (2015)
Level I
Quality A

Dobleblinded RCT.
156 adults
ASA II-IV

Cardiac
surgery

Methadone
group, n=77,
received
0.15mg/kg
methadone on
anesthesia
induction and
0.15mg/kg
methadone
infusion over the
next 2 hours.

Fentanyl group,
n=79 received
6mcg/kg of
fentanyl on
anesthesia
induction and
6mcg/kg infusion
over the next 2
hours.

Udelsmann
et al.11 (2011)

Doubleblinded RCT.
55 adults
ASA III-IV

Cardiac
surgery
with CPB

Methadone
group, n=18,
received 20mg
methadone on
anesthesia
induction.

Morphine group,
n=19, received
20mg morphine
on anesthesia
induction &
placebo (saline)
on anesthesia
induction. All
groups received
identical doses of

Level I
Quality B

out of 10.
Both patient
groups were
then
transitioned
to
hydromorph
one PCA
with
identical
settings.
Both groups
started oral
opioid
therapy on
POD 2.
Morphine
2mg
administered
in ICU until
pain scores
<3. Oral
pain
medications
(hydrocodon
e 5mg and
APAP
325mg
either 1 or 2
tablets)
initiated on
POD 2 for
moderate to
severe pain.

Morphine
0.03mg/kg
as necessary
based on
pain
assessment

patients were being
transitioned from PCA
hydromorphone to
hydrocodone 10mg and
acetaminophen 325mg
tablets, and total oral
opioid requirements
were less in this group.

Postoperative morphine
requirements during the
first 24h were reduced
from a median of 10mg
in the fentanyl group to
6mg in the methadone
group, P < 0.001. Total
morphine use over the
first 72h was less in the
methadone group, P <
0.001. Reductions in
pain scores with
coughing were observed
during the first 24h after
extubation; the level of
pain with coughing at 12
h was reduced from a
median of 6 in the
fentanyl group to 4 in the
methadone group, P <
0.001. Improvements in
patient-perceived quality
of pain management
were described in the
methadone group. The
incidence of opioidrelated adverse events
was not increased in
patients administered
methadone.
The number of patients
who needed analgesics
was significantly lower
in the methadone group
(P=0.025). 45% of the
methadone patients, 26%
of the morphine patients,
and 11% of the control
patients required no
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Gottschalk
et al.10 (2011)
Level I
Quality A

Simoni et al.9
(2009)
Level I
Quality A

Chui et al.24
(1992)
Level I
Quality A

Singleblinded RCT.
29 adults
ASA I-II

Multilevel
thoracolu
mbar
spine
surgery

Methadone
group, n=13,
received
0.2mg/kg
methadone after
anesthesia
induction

Doubleblinded RCT.
126 adults
ASA I-II

Video
laparosco
pic
procedure
s

Methadone
group, n=42,
received
0.1mg/kg
methadone after
anesthesia
induction

Doubleblinded RCT.
30 adult
females ASA
I-II

Abdomina
l
hysterecto
my

Methadone
group, n=15,
received
0.25mg/kg
methadone on
anesthesia
induction

sufentanil on
induction and
maintenance of
anesthesia.
Sufentanil group,
n=16, received
loading dose
before incision
and infusion
during
maintenance. In
both groups
sufentanil,
0.1mcg/kg bolus
was utilized to
treat inadequate
anesthesia.

Clonidine group,
n=42, received
2mcg/kg
clonidine after
anesthesia
induction &
Placebo group,
n=42, received
saline after
anesthesia
induction. In all
groups,
remifentanil was
administered on
induction and
maintenance. All
groups received
ketoprofen
1.5mg/kg and
dipyrone 30mg/kg
Morphine group,
n=15, received
0.25mg/kg
morphine on
anesthesia
induction

postoperative morphine
in first 24 h
In both
groups,
postoperativ
e analgesia
included the
use of PCA
(fentanyl,
morphine, or
hydromorph
one at the
discretion of
the attending
neurosurgeo
n)
Intravenous
tramadol
(1.5 mg/kg)
was the
rescue
analgesic if
the patient
reported
pain

Methadone reduced
postoperative opioid
requirement by
approximately 50% at 48
hours (sufentanil versus
methadone group,
median [25%/75%
interquartile range]: 63
mg [27.3/86.1] vs 25 mg
[16.5/31.5] morphine
equivalents, P=0.023;
and 72 hours: 34 mg
[19.9/91.5] vs 15 mg
[8.8/27.8] morphine
equivalents, P=0.024)
after surgery
The incidence of pain in
the methadone group
was significantly lower
than in the clonidine and
placebo groups which
resulted in less tramadol
consumption. (11, 21,
and 23, respectively; P<
0.02).

Methadone
group
allocated to
3-4.5mg
boluses in
PACU and
morphine
7.5mg IM as
needed in
surgical
ward.
Morphine
group
allocated to
3-4.5mg
boluses in

After returning to the
ward, patients in the
methadone group
requested fewer doses of
supplementary opioids
than those in the
morphine group (P<
0.001). 67% of patients
given methadone
required no further pain
medication on PODs 1
and 2; 100% of patients
given morphine required
at least two doses of
postoperative pain
medication.
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Richlin et
al.28 (1991)
Level I
Quality B

Gourlay et
al.26 (1986)
Level I
Quality A

Singleblinded RCT.
40 adult
females ASA
I-II

Abdomina
l
hysterecto
my or
myomecto
my

Methadone
group, n=20,
received 20mg
methadone on
anesthesia
induction.

Morphine group,
n=2, received
20mg morphine
on anesthesia
induction

Doubleblinded RCT.
20 adults
ASA I-II

Open
upper
abdomen
procedure
s

Methadone
group, n=10,
received 20mg
methadone on
anesthesia
induction

Morphine group,
n=10, received
20mg morphine
on anesthesia
induction

PACU and
morphine
7.5mg IM as
needed in
surgical
ward.
Methadone
group
received
subsequent
dosing in
PACU and
surgical
ward.
Morphine
group
received
subsequent
dosing in
PACU and
surgical
wards.
Methadone
group
allocated to
additional
methadone5
mg doses in
PACU and
surgical
ward.
Morphine
group
allocated to
additional
morphine
5mg doses
in PACU
and surgical
ward

Patients who received
methadone (combined
intraoperative and
recovery room doses)
reported less pain and
required minimal
additional analgesic over
the next 72 hours than
did patients who
received morphine.
Analgesic requirements
were reduced by 60% in
the methadone group
compared to the
morphine group 1.9 ±
0.3 methadone group;
3.4 ± 0.5 morphine
group during POD 1–3.
The time from initial
pain control to the first
supplementary dose in
the surgical ward was
significantly different
(P<0.01) in the
methadone group (20.7
+/- 20.2 h) when
compared to the
morphine group (6.2 +/3.0 h). Further, patients
required significantly
less (P<0.001)
methadone (11.5 +/- 8.5
mg) than morphine (41
+/- 14.1 mg) in the
surgical ward to provide
adequate pain relief
throughout the duration
of the study (i.e., 60 h)

DISCUSSION OF LITERATURE REVIEW
Summary of Evidence
Fifteen RCTs with a total of 1,119 patients were included in this quality improvement
project. Several studies were omitted for the following reasons: the studies measured different
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primary outcomes, exclusion of methadone administration during the perioperative period, or a
different study design. Of the fifteen level I evidence articles, thirteen were rated as high quality
and two were rated as a good quality based on The Johns Hopkins Evidence-Based Practice
Evidence Level and Quality Guide.41 Due to larger sample sizes, well-defined methodology and
inclusion criteria, as well as arduous statistical methods, thirteen of the articles met the criteria
for high-quality level I evidence.9,10,13-16,18-20,22-24,26 The remaining two articles appraised utilizing
The Johns Hopkins Evidence-Based Practice Evidence Level and Quality Guide, met the criteria
as good-quality level I evidence, due to smaller sample sizes, mediocre methodology, limited
statistical analysis, or poorly defined inclusion criteria.11,28
Of the fifteen articles analyzed, fourteen recommended the use of methadone during the
perioperative period and found its use associated with a reduction in postoperative opioid
consumption, superior analgesia, or improved patient satisfaction. Moro et al. concluded that
pain scores and quality of recovery did not differ significantly between patients undergoing
laparoscopic cholecystectomy under total intravenous anesthesia who received either methadone
or morphine for postoperative analgesia.20 The results of this quality improvement protocol are
summarized below:
§

Two studies found superior postoperative analgesia and reduced postoperative opioid
consumption 24 hours after surgery when methadone 0.1mg/kg was administered during
the perioperative period.9,15

§

One study found patients treated with methadone had significantly lower pain 24 hours
after surgery and no significant difference in postoperative opioid consumption when
methadone 0.2mg/kg was administered after anesthesia induction.23
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§

One study found no significant difference in postoperative pain and opioid consumption
when methadone 0.1mg/kg was administered on anesthesia induction.20

§

Four studies found superior postoperative analgesia and reduced postoperative opioid
consumption 24 to 72 hours after surgery when methadone 0.15mg/kg bolus was
administered on anesthesia induction.13,16,19,22

§

Seven studies found superior postoperative analgesia, improved patient satisfaction, and
reduced postoperative opioid consumption 24 to 72 hours after surgery when methadone
0.2mg/kg with a maximal dose of 20mg was administered during anesthesia
induction.10,11,14,18,24,26,28

Limitations of the Systematic Review
Limitations of the research include published languages other than English or studies
published in non-indexed journals. Additionally, there is high heterogeneity among the included
studies. There were several inconsistencies between the 15 RCTs, raising the potential to
negatively influence the reliability of this quality improvement project. One fundamental
difference was that patients underwent a wide range of surgical procedures, which represent
dissimilar nociceptive stimuli, representing inconsistency biases. Another limitation is the
dissimilar range of postoperative follow-up and data collection, three studies limited their
investigation to 24 hours,9,11,20 one study limited their investigation to 36 hours,15 four studies
limited their investigation to 48 hours,22-24,26 five studies limited their investigation to 72
hours,10,13,14,18,28 one study limited their investigation to 1 month,19 and one study limited their
investigation to 3 months.16
Additionally, the timing and dose range of methadone administration was highly variable
among the 15 RCTs. Eleven studies used methadone in analgesic bolus doses ranging from 0.1 to
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0.3 mg/kg at the beginning of the surgical procedure,13,14,16,18-20,22-24,26,28 three studies used
methadone 20 mg after anesthesia induction,9-11 and one study used methadone 0.1 mg/kg at the
end of the procedure.15 Nine studies used methadone as the sole opioid during anesthesia, 13,16,1820,22,24,26,28

while six studies used methadone co-administered with other opioids in the

intervention group.9-11,14,15,23
There was also vast heterogeneity in intraoperative anesthetic technique, analgesic use,
and postoperative analgesia management among the included studies. Intraoperative anesthetic
approach displayed a range from inhalational-based general anesthesia to total intravenous
anesthesia among the 15 RCTs included. Four studies disclosed the use of multimodal analgesics
in both the experimental and control groups, agents administered include gabapentin,
dexamethasone, ketoprofen, and dipyrone.9,14,16,20 Postoperative analgesia management also
showed a range of approaches from PCA to nurse administered bolus when requested. Overall,
the heterogeneity between studies may question the reliability of this quality improvement
project.
Another limitation was the number of study participants included in the RCTs was mostly
small (e.g., 20 participants) to medium effect size (e.g., 156 participants). Because of the sample
sizes, a larger effect size may be reported and lead to reporting bias. An additional limiting factor
of the studies includes research at a single center; whereas including multiple facilities with
larger sample sizes would allow results to be more generalized.
The study participants consisted of 18 to 65 years of age, including both male and female,
healthy ASA I-II patients and ASA III-IV with severe systemic disease. Exclusion of patients
occurred with severe liver or renal pathology independent of ASA physical status and was
embedded in the inclusion criteria to avoid methadone toxicity and subsequent adverse events.
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All participants were scheduled for elective surgery so these findings cannot be concluded to
patients presenting for emergency surgeries. Despite these limitations, this quality improvement
project overall supports the use of single-dose intraoperative methadone 0.15-0.2 mg/kg in adult
surgical patients to provide superior postoperative analgesia and reduce postoperative opioid
consumption after surgery.
Risk of Bias
Eleven studies were categorized as having a low risk for selection bias since all samples
were randomized and allocation concealment was described.9,10,13-16,18-20,22,23 Four studies were
categorized as having unclear risk for selection bias as information in the articles was not
sufficient or not properly reported in the studies.11,24,26,28 Eleven studies were categorized as
having a low risk for performance bias since blinding of participants and personnel was
achieved.9,13-16,18-20,22,23,26 Chui et al.24 and Udelsmann et al.11 were categorized as having unclear
risk for performance bias and Gottschalk et al.10 and Richlin et al.28 were categorized as having a
high risk for performance bias.
Twelve out of the fifteen studies were categorized as having a low risk for detection bias
since blinding of outcomes was sufficiently described in the articles.9-11,13,15,16,18-20,22,23,26 Three
studies were classified as having unclear risk for detection bias.14,24,28 Twelve studies included in
this quality improvement project were characterized as having a low risk for attrition bias since
incomplete outcome data was not present in the study.9-11,14-16,18-20,22,23,26 The remaining three
articles were evaluated as having an unclear risk for attrition bias.13,24,28 Four studies in this
systematic review were evaluated as high risk for reporting bias as selective reporting was
apparent.9,11,15,28 The remaining eleven studies were categorized has having low risk for reporting
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bias.10,13,14,16,18-20,22-24,26. Assessment of these incidences of bias must be taken into consideration
when reviewing the findings and results of each study.
Recommendations for Future Research
To further reduce and improve patients’ postoperative pain experience, additional
research must focus on being homogenous including the use of high-quality methodology design
and making outcome measurements similar to other published studies to have fair comparisons.
Additional large multi-center RCTs of high methodological quality are necessary to set the
evidence and clarify concerns regarding for use of methadone to treat or mitigate acute postsurgical pain. Based on the evidence from the appraised RCTs, a minimal effective single dose
of methadone 0.15-0.2mg/kg with a dose maximum of 20mg administered during anesthesia
induction significantly reduced postoperative opioid consumption 24 to 72 hours after surgery,
improved postoperative analgesia, and or achieved higher patient satisfaction with postoperative
pain management.10,11,13,14,16,18,19,22-24,26,28 However, further research is required to determine the
ideal timing and dose of perioperative methadone to achieve the maximum benefit while
achieving a lack of potential side effects in specific patient surgical populations. Additionally,
further research is necessary to investigate the use of methadone in high-risk patient populations
such as the elderly and those with severe liver or renal pathology.
Bastian et al. identified no statistically significant prolongation in QTc in patients treated
with a single intraoperative bolus of methadone,18 however, further large-scale RCTs are
required to replicate this result and make it more generalizable. Lastly, the role of methadone in
enhanced recovery after surgery (ERAS) protocols should be investigated. The reduction of
postoperative opioids associated with the administration of methadone appears to be particularly
useful in this regard. Additional research is needed to determine the effect of methadone on
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bowel function, patient-reported quality of recovery, hospital length of stay, and outcomes after
discharge in ERAS protocols.5
Evaluating the pharmacoeconomics in the choice of methadone for analgesia might be of
interest to improve cost-effectiveness. No studies included in this review discussed the costeffectiveness of intravenous methadone compared to short-acting opioids. Cost of intravenous
opioids are as follows: morphine sulfate solution 2mg/mL $3.44, hydromorphone hydrochloride
solution 1mg/mL $2.22-$4.50, fentanyl citrate solution 100mcg/2mL $2.50, and methadone
hydrochloride solution 200mg/20mL $21.00-$23.34. Additional research is required to
investigate if utilizing methadone for the treatment of acute surgical pain will lead to cost
savings attributed to its potent opioid-sparing property.
Recommendations for Practice
No single intervention can safely reduce or eliminate the incidence of postoperative pain,
the use of multimodal analgesics, regional anesthesia techniques, and shorter-acting opioids are
considered to be the standard of care. Although the aforementioned strategies are effective and
serve essential roles in the treatment of acute surgical pain, patient outcomes are lacking and
improvements must be made. Satisfactory postoperative pain management is a fundamental right
of patients and an obligation of anesthesia providers. The trend in anesthesia care has focused on
the utilization of short-acting opioids such as fentanyl, sufentanil, and the novel agent,
remifentanil. It should be axiomatic that the duration of analgesia should be parallel to the
duration of postoperative pain. A paradigm shift needs to occur with the utilization of methadone
in the perioperative setting for increased quality of care, patient satisfaction, and decreased costs.
Methadone is a potent μ-receptor agonist with several unique properties: it is a synthetic
opioid with the longest elimination half-life of 24 to 36 hours;27 it possess NMDA receptor
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antagonist activity which can prevent opioid tolerance, hyperalgesia, and chronic post-surgical
pain;7,42,43 and inhibits the reuptake of serotonin and norepinephrine in the brain potentially
improving mood and perception of pain.8 Although the pharmacokinetics and pharmacodynamics
of methadone administered during the perioperative period has been thoroughly studied in both
adults and children,27,44 several misconceptions remain with anesthesia providers regarding its
use in the perioperative period.
One such misconception relates to methadone being inappropriate intraoperatively due to
the slow onset of action. When administered intravenously, methadone has a rapid onset of
action, with central nervous system effect-site concentration equilibrating rapidly with serum
concentrations yielding a t1/2ke0 of 7-8 minutes.27,45 This is comparable to the rapid onset of
action and effect-site concentration equilibration of fentanyl, t1/2ke0 of 5-6 minutes.6 Meaning
methadone is a viable option to produce rapid analgesia, which is typically required
intraoperatively.
Based on the evidence in this review, a minimal effective single dose of methadone 0.150.2mg/kg with a max dose of 20mg administered at induction of anesthesia is a viable strategy to
produce intraoperative analgesia as well as long-lasting postoperative analgesia and reduction of
postoperative opioids 24 to 72 hours after surgery. Additionally, the peak respiratory depressant
effect of methadone occurs approximately 8 to 10min after administration.6 When administered
on induction of anesthesia, the peak respiratory depressant effect occurs at a time when the
airway is secured and ventilation controlled, and the duration of the surgery will allow sufficient
time for spontaneous recovery of ventilation.5 Due to the long elimination time of methadone,
data suggests that repeat dosing intraoperatively should be avoided.27
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The evidence gathered from the 15 RCTs included in this review has deemed methadone
administration safe during the perioperative period in adult surgical patients undergoing a wide
range of surgical procedures including ambulatory same-day procedures, cardiac, spinal fusion,
open abdominal, vascular, orthopedic, breast, thoracic, and bariatric surgeries. Ideal candidates
to receive methadone include those undergoing moderately to severely painful surgeries,
surgeries associated with chronic pain, absence of opioid abuse disorder, and exclusion of
functional hepatic or renal pathology. Provided below in Figure 2 are considerations based on the
evidence found in this systematic review suggested for anesthesia providers’ clinical practice.
Figure 2. Intraoperative Methadone Considerations

Preoperative

• Patients presenting for elective moderately to severely painful
procedures inlcuding spinal fusion, cardiac, open abdominal,
vascular, orthopedic, thoracic, breast, bariatric, and surgeries
associated with chronic pain are ideal candidates.
• Exclude patients with functional renal or hepatic pathology, opioid
abuse disorder, or physiologically aged.

• Intraoperative single dose of methadone 0.15mg/kg with a max
dose of 20mg intravenously given on induction of anesthesia.
• Strongly advised to administer methadone on induction of
anesthesia or shortly after.
Intraoperative • Avoid re-dosing methadone. Consider other short duration opioids
intraoperatively to treat signs of inadequate analgesia

• Peak respiratory depressant effects of methadone occur 8-10
minutes after administration, if administered on induction of
anesthesia, this occur at a time when ventilation is controlled.
• Recovery of anesthesia in PACU should include standard
monitoring.
• If respiratory depression is suspected to be attributed to
Postoperative methadone, consider naloxone infusion of 0.25-6.25mg/hr to
maintain adequate minute ventilation as naloxone has a short halflife (90 minutes).
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CONCLUSION
Methadone is the longest-acting opioid clinically available with a unique
pharmacokinetic profile that has several advantages. Randomized clinical trials in patients
undergoing a variety of surgical procedures including open abdominal surgery, robotic-assisted
and laparoscopic abdominal surgeries, same-day ambulatory surgeries, bariatric surgery, cardiac
surgery, spine surgery, and orthopedic surgeries have presented high-quality evidence that the
administration of intraoperative methadone significantly reduces post-operative pain and postoperative opioid consumption 48 hours after surgery. For open abdominal, complex spine, open
thoracic, or for healthy ASA I-II patients undergoing very painful surgeries a single
intraoperative dose of methadone 0.15mg/kg with a maximum dose of 20mg on the induction of
anesthesia is appropriate. Smaller doses of methadone 0.1mg/kg have been utilized in the elderly
population or those with severe physiologic limitations safely.
It is uncertain why the administration of methadone to surgical patients is not a common
strategy to improve postoperative pain and reduce postoperative opioid consumption. Lack of
knowledge among anesthesia providers regarding the pharmacokinetic profile of methadone,
uncertainty about the duration of action, concerns about prolonged respiratory depression, and
use in opioid use disorder may be at play among anesthesia providers.
QUALITY IMPROVEMENT PROJECT
The primary objective of this quality improvement project is to assess the healthcare
providers’ current knowledge on the use of methadone administration in the operating room and
its associated clinical benefits. To successfully achieve the goal of this quality improvement
project, a series of actions will be conducted that involved a specific group of anesthesia
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providers willing to take part in the intervention. These actions will be identified in the sections
and each section of the methodology is crucial to determining the study outcome.
Settings and Participants
The study will take place at Mount Sinai Medical Center located in Miami Beach,
Florida, and will solely focus on Miami Beach Anesthesiology Associates (MBAA). MBAA is a
privately owned anesthesia practice that provides anesthesia services at Mount Sinai Medical
Center, the primary study participants will be Anesthesiologist and CRNAs employed by
MBAA. The participants will be contacted and recruited through the MBAA email list making
participation completely voluntary.
The participants will be provided a survey link with the educational intervention which
consists of a pre-test, voice-over PowerPoint educational module, and post-test. All participants
will be asked to provide feedback regarding their experiences with the educational program. The
anticipated sample size will be between 5-10 participants.
Description of Approach and Project Procedures
The primary methodology of the proposed project is to administer an online educational
intervention composed of a narrated PowerPoint to providers that focus on the main clinical
benefits of methadone administration to surgical patients. A survey will be composed of three
phases will be distributed via email to the email list provided by MBAA. The first phase of the
project will be composed of a pre-assessment survey that will collect demographic data and
identify the participant’s baseline knowledge regarding methadone use in surgical patients.
Existing knowledge will be identified using the pre-assessment survey, the data collected will be
utilized to compare the impact achieved by the voice-over PowerPoint presentation.
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Once the surveyors complete the pre-assessment survey in phase one, the second phase
will follow which will contain a narrated PowerPoint presentation. The primary means of
learning will be an online PowerPoint presentation with key information regarding methadone’s
pharmacokinetics, pharmacodynamics, indications, dosage, clinical effects, and safety
considerations. The surveyor will be able to click and view this information.
The third phase of the project will involve the completion of the post-assessment survey
to identify the learned knowledge of the project and the likelihood of using methadone in future
anesthesia practice. The data collected will provide feedback regarding the impact of the
educational intervention and will determine the efficacy of the participants learning. The pre and
post-surveys will be compared and analyzed in extracting relevant information regarding the
effectiveness of the online intervention. At the end of the educational tool, feedback will also
demonstrate if the educational module requires changes going forward and if the providers will
benefit from the future projects being presented in an online format in the future.
Protection of Human Subjects
For this study, the recruitment population will include Anesthesiologist and CRNAs that
are employed by MBAA and administer anesthesia services at Mount Sinai Medical Center. This
population is essential because major painful surgeries are performed at this facility and
postoperative opioid use is common. Recruitment activities will be conducted by email
invitations to all anesthesiologists and CRNAs currently employed and practicing at Mount Sinai
Medical Center. MBAA will provide their email list allowing their anesthesia members to be
utilized for this educational intervention. If the anesthesia providers agree to participate, they
will click on the link provided in the email which will prompt them to complete the three-phase
survey. There will be no penalties if any participants who decide to withdraw from the QI
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project. There are no perceived risks to the study as it only requires the time spent by each
participant in the educational intervention.
Data Collection
For the study, the primary instruments to be used will include a pre-survey and postsurvey testing applications to determine the effects of the intervention. Both tests will be
conducted by utilizing a three-phase survey developed in Qualtrics. The survey will be composed
of the pre-assessment survey, followed by the video presentation and post-assessment survey.
The data collected will determine if participants have a clear understanding of the administration
of methadone to surgical patients to reduce post-operative pain and opioid consumption based on
the most recent data. The pre-survey questionnaire and post-survey questionnaire will be the
same composed of 15 questions that focus on current practice and baseline knowledge using
Qualtrics. In this manner, the pre-assessment survey will gauge knowledge in the educational
program and its purpose while the post-assessment survey will determine if the participants have
learned from the intervention and application of their knowledge to the surgical practice
environment. The instrument reliability and validity will be measured in accordance with the
intervention and its effectiveness for the providers. The data collected will be confidential and no
subject identifiers will be recorded during any component of the study.
Data Management and Analysis Plan
The co-investigator for the project will be the DNP student who will be responsible for
administering the survey. The investigator conducted the statistic that will be utilized to evaluate,
compare, and analyze the pre-assessment and post-assessment. Each question will be compared
and analyzed, and the responses recorded to identify the knowledge base before and after the
intervention was provided. No personal identifiers will be recorded or requested, this assures the
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protection of the study participant's confidentiality. The impact of the intervention will be
measured solely on the results of the pre and post-assessment survey questions. Through the
statistical analysis, the study results will likely identify patterns that will be used to determine the
effectiveness of the educational intervention. The co-investigator will store the data collected in a
password-protected laptop computer.
QUALITY IMPROVEMENT PROJECT RESULTS
Demographic Data
Participant demographic data was collected and analyzed as shown in Table 4. There was
a total of nine participants that fully completed the pre-assessment survey, attended the online
educational modules, and completed the post-assessment survey. The age ranges represented
were 20 to 30 years of age (n=3, 33.33%), 31 to 49 years of age was the most represented age
group (n=5, 55.56%), and greater than 50 years of age (n=1, 11.11%). Most of the participants
were male (n=5, 55.56%) with the remainder of the participants (n=4, 44.44%) identifying as
female. There were also a range of ethnicities represented: African American (n=1, 11.11%),
Asian (n=1, 11.11%), Caucasian (n=0, 0%), Other (n=1, 11.11%), and Hispanic (n=6, 66.67%).
All the participants were CRNAs (n=9, 100%). The participants were questioned about
the length of time in delivering anesthesia services, the data collected produced a practice period
range: less than one year (n=0, 0%), 1 to 5 years of practice (n=6, 66.67%), 6 to 10 years of
practice (n=1, 11.11%), and greater than 10 years of practice (n=2, 22.22%). Lastly, all
participants indicated to be doctorally prepared practitioners receiving DNP, DNAP, EdD, or
Ph.D. (n=9, 100%).
Table 4. Participant Demographics
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Demographics

n (%)

Total Participants

9 (100%)

Gender
Male
Female

5 (55.56%)
4 (44.44%)

Age
20-30
31-49
>50
Ethnicity
African American
Asian
Caucasian
Other
Hispanic
Position/Title
CRNA
Physician (MD/DO)
Years in Practice
Less than 1
1 to 5 years
6 to 10 years
>10 years
Level of Education
Associates
Bachelors
Masters
Doctoral

3 (33.33%0
5 (55.56%)
1 (11.11%)
1 (11.11%)
1 (11.11%)
0 (0%)
1 (11.11%)
6 (66.67%)
9 (100%)
0 (0%)
0 (0%)
6 (66.67%)
1 (11.11%)
2 (22.22%)
0 (0%)
0 (0%)
0 (0%)
9 (100%)

Pre-Assessment Survey Current Methadone Knowledge Results
This section of the survey focuses on the participant’s current knowledge of methadone
administration in surgical patients before the educational module intervention. Questions are
tailored to assess participants’ awareness of post-operative pain, chronic surgical pain,
pharmacokinetics and pharmacodynamics of methadone, indications, contraindications, dosage,
clinical benefits, and safety considerations. First, most participants (n=5, 55.55%) incorrectly
identified that the incidence of postoperative pain occurs in only 60% of the post-operative
population, only 4 participants (n=4, 44.44%) selected the correct of 80% incidence based on
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current evidence. Second, most participants (n=7, 77.78%) were able to identify the correct
mechanism of action of methadone, while only 2 participants (n=2, 22.22%) mistakenly selected
the wrong mechanism of action. Third, many of participants (n=7, 77.78%) correctly identified
methadone’s effect-site equilibration time of 7-8 minutes after an IV dose, while only 2
participants (n=2, 22.22%) incorrectly selected 30 minutes. This represents some uncertainty
among anesthesia providers regarding the pharmacodynamics of methadone.
Most participants (n=8, 88.89%) identified methadone as the opioid with the longest
elimination half-life. There was a significant difference in answers when questioned about the
peak respiratory depressant effects of methadone after its administration, with eight participants
(n=8, 88.89%) incorrectly indicating peak respiratory depressant effects at 60-120 min, only one
participant (n=1, 11.11%) correctly identified that peak respiratory effects occur at 8-10 minutes.
This may reflect the misconception of methadone’s onset of action time among anesthesia
providers seeing it as an inappropriate agent for intraoperative analgesia. Lastly, all participants
(n=9, 100%) correctly identified methadone’s clinical effects of potent intraoperative analgesia,
long-lasting postoperative analgesia, and reduced opioid consumption up to 48 hours after
surgery. Detailed analysis report for the pre-assessment survey results, which represents
participant’s current knowledge of methadone before the educational module is provided in
appendix E.
Post-Assessment Survey Methadone Knowledge among Anesthesia Providers
Detailed analysis report for the post-assessment survey results, which represents
participant’s knowledge of methadone after reviewing the educational module is provided in
appendix F. See Table 5 below for a comparison of pre-assessment survey results and postassessment survey results after participants participating in the educational module.
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Table 5. Difference in Pre-and Post-Assessment Knowledge of Methadone
Questions

PreAssessment

PostAssessment

Difference

The incidence of postoperative pain can be as high as

44.44%

77.78%

33.34%

Methadone’s clinical effect can be attributed to what three
essential mechanisms of action?

77.78%

100%

22.22%

Select the opioid with the longest elimination half-life

88.89%

100%

11.11%

Select the effect-site equilibration of an intravenous bolus
dose of methadone.

77.78%

100%

22.22%

What population of surgical patients can benefit from the
clinical effects of methadone administration?

100%

100%

0%

A single dose of methadone 0.15-0.2 mg/kg administered
on the induction of anesthesia produces what clinical
effects

100%

100%

0%

The Peak respiratory depressant effect of methadone
occurs at what time after administration?

11.11%%

77.78%

66.67%

What dose range of methadone is appropriate to
administer on induction of anesthesia?

100%

100%

0%

Methadone should be excluded from patients presenting
for elective surgery with which disease process.

88.89%

100%

10.11%

In Table 5, participant knowledge of methadone is compared between pre-assessment
survey and post-assessment survey results based on the percentage of participants that were able
to select the correct answer to the corresponding question. Overall, participant knowledge of
methadone utilization in surgical patients did improve after receiving the evidence-based
educational module and this is reflected by higher scores in most of the post-assessment survey
questions. Based on the results, it appears that most participants are aware of the main surgical
populations that benefit from receiving methadone and the correct dose as all participants
correctly identified the answer in the pre-assessment and post-assessment survey, this yields a
0% difference.

53
Participant knowledge significantly improved after the educational module in correctly
identifying the incidence of post-operative pain generating 33.34% improvement. Likewise, after
the educational module, there was a 66.67% increase of participants that were able to correctly
identify the peak respiratory depressant effect of methadone occurring 8 to 10 minutes after
administration.
Summary
Overall, the results reflect an improvement in methadone knowledge based on the preassessment and post-assessment survey results. Knowledge showed an average improvement of
11%. Before the educational module, pre-assessment survey results demonstrated that 67% of
participants (n=6) were either extremely likely or somewhat likely to utilize methadone. After
the educational module, post-assessment survey results demonstrated that 78% of participants
(n=7) were either extremely likely or somewhat likely in utilizing a single intraoperative dose of
methadone. The information provided in the educational module tackled some common
misconceptions about the use of methadone with current evidence which allows participants to
be more accepting and confident in the future use of methadone in surgical patients. Based on the
results, the educational module increased anesthesia providers’ knowledge of post-operative
pain, chronic surgical pain, pharmacokinetics and pharmacodynamics of methadone, indications,
contraindications, dosage, clinical benefits, and safety considerations.

Figure 3. Pre-Assessment Survey Results before Educational Module
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Figure 4. Post-Assessment Survey Results after Educational Module
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QUALITY IMPROVEMENT PROJECT DISCUSSION
Limitations
Limitations of the study include a small sample size; the survey was emailed to the
MBAA email list which was composed of 31 emails but only 9 participants completed the study.
Larger sample size is preferable to strengthen the results of the study as well as provide a sample
population that reflects the anesthesia providers at Mount Sinai Medical Center. The survey link
which contained the pre-test narrated PowerPoint presentation and post-test was online available
for two weeks, increasing the timeline may have generated more responses. The email with the
request to participate in the study was sent only once, follow-up emails might have also aided in
generating more responses. Lastly, the project was implemented completely online hindering its
delivery by other methods.
Future Implications to Advanced Nursing Practice
The outcomes of the study supported the increase in knowledge in determining strategies
available to anesthesia providers for disseminating information that educates new drug regimens,
dosages, side effects, complications, and pharmacological therapy. Improving knowledge of
novel drugs and therapies utilized for analgesia impacts anesthesia providers to utilize the
empirical evidence for best practice and patient safety. Published articles encompass different
topic areas and it is imperative to provide a method that effectively translates the research to
practice for anesthesia providers.
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Appendix C: Proposed Method for Data Collection Pre-Survey and Post-Survey

Pretest and Posttest Questionnaire:
Educational Intervention Regarding the Effectiveness of Single Dose Intraoperative
Methadone Reducing Post-Operative Opioid Consumption at 24-48 Hours: A Quality
Improvement Project
INTRODUCTION
The primary aim of this QI project is to improve the knowledge of CRNAs pertaining to the
utilization of intravenous methadone during the intraoperative period to reduce post-operative
opioid consumption 24 to 48 hours after surgery.
Please answer the question below to the best of your ability. The questions include
demographic information and knowledge of methadone utilization in adult surgical patients.
Questions are either in multiple-choice or Likert style format and are meant to measure the
anesthesia provider’s knowledge of the effectiveness of intraoperative methadone reducing postoperative opioid consumption.
PERSONAL INFORMATION
1. Gender: Male
Female
Other________
2. Age: ______
3. Ethnicity:
Hispanic
Caucasian
African American
Asian
Other_______________
4. Position/Title: _________________________________
5. Level of Education: Associates
Bachelors
Masters
Doctoral (DNP,
DNAP, EdD, PhD, MD) _______
6. Years of experience: Less than 1 year
1 to 5
6 to 10
more than 10 year

QUESTIONNAIRE
1. The incidence of post-operative pain can be as high as:
a. 20%
b. 40%
c. 60%
d. 80%
2. The incidence of acute post-operative pain transitioning to chronic surgical pain can
occur in what percentage of patients undergoing surgical procedures:
a. 10-15%
b. 0%
c. 50%
d. 100%
3. Poorly managed acute post-operative pain can result in alterations of which
physiological functions?
a. Increased myocardial demand
b. Hypoventilation
c. Impaired immune function
d. All of the above
4. Methadone’s clinical effect can be attributed to what three essential mechanisms of
action?
a. Potent μ-receptor agonist, N-Methyl-D-aspartate receptor antagonist, and
Reuptake inhibition of serotonin and norepinephrine
b. Delta receptor antagonist, kappa receptor antagonist, and sodium channel blocker
c. Non-selective alpha antagonist, beta adrenergic antagonist, GABA-B antagonist
d. Inhibition of alpha 2 delta subunit of voltage-gated calcium channels, GABA-A
agonist, and muscarinic antagonist
5. Select the opioid with the longest elimination half-life
a. Methadone
b. Fentanyl
c. Morphine
d. Remifentanil
6. Select the effect-site equilibration of an intravenous bolus dose of methadone.
a. 60 minutes
b. 7-8 minutes
c. 30 minutes
d. 1 minute
7. What population of surgical patients can benefit from the clinical effects of
methadone administration?
a. Spinal fusion
b. Open abdominal
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c. Orthopedic
d. Bariatric
e. All of the above
8. A single dose of methadone 0.15-0.2 mg/kg administered on the induction of
anesthesia produces what clinical effects.
a. Potent intraoperative analgesia, long-lasting post-operative analgesia, and
reduction of post-operative opioid consumption up to 48 hours after surgery
b. Torsades de Pointes
c. Opioid dependence
d. Prolonged extubation time
9. The Peak respiratory depressant effect of methadone occurs at what time after
administration?
a. 60 to 120 minutes
b. 8 to 10 minutes
c. 5 minutes
d. 1 minute
10. A patient received methadone 0.15 mg/kg on induction of anesthesia and is now
displaying persistent signs of severe pain with surgical stimulation. Select the best
intervention.
a. Re-dose methadone 0.15 mg/kg
b. Administer a rapid-acting opioid (i.e., fentanyl, remifentanil, alfentanil)
c. Administer a muscle relaxant
d. No intervention is required
11. What dose range of methadone is appropriate to administer on induction of
anesthesia?
a. 0.15-0.2 mg/kg (max of 20mg)
b. 1-2 mg/kg
c. 5 mg/kg
d. 10 mg/kg
12. Methadone should be excluded from patients presenting for elective surgery with
which disease process.
a. Impaired renal function
b. Impaired hepatic function
c. Obesity
d. Both A and B
13. Select the best intervention if respiratory depression is evident and suspected to be
attributed to methadone administration.
a. Consider single flumazenil bolus 0.2mg
b. Consider single glucagon bolus 1mg
c. Consider single naloxone bolus 0.1mg
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d. Consider naloxone infusion 0.25-6.25 mg/hr
14. How likely are you to use alternative therapies in surgical patients to reduce postoperative opioid consumption?
a. Most likely
b. Somewhat likely
c. Somewhat unlikely
d. Most unlikely
15. How likely are you to utilize a single intraoperative dose of methadone to reduce
post-operative opioid consumption up to 48 hours after surgery?
a. Most likely
b. Somewhat likely
c. Somewhat unlikely
d. Most unlikely
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Appendix E: Pre-Assessment Survey Results Report
Q8 - The incidence of post-operative pain can be as high as:

#
1

Field Minimum Maximum Mean
The incidence of post-operative
pain can be as high as:

1.00

4.00

Std
Variance Count
Deviation

3.22

0.92

0.84

9

#

Answer

%

Count

1

20%

11.11%

1

2

40%

0.00%

0

3

60%

44.44%

4

4

80%

44.44%

4

Total

100%

9
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Q9 - The incidence of acute post-operative pain transitioning to chronic surgical pain can occur in
what percentage of patients undergoing surgical procedures:

#

1

Field Minimum Maximum Mean
The incidence of acute postoperative pain transitioning to
chronic surgical pain can occur
in what percentage of patients
undergoing surgical procedures:

1.00

3.00

Std
Variance Count
Deviation

1.22

0.63

0.40

9

#

Answer

%

Count

1

10-15%

88.89%

8

2

0%

0.00%

0

3

50%

11.11%

1

4

100%

0.00%

0

Total

100%

9
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Q10 - Poorly managed acute post-operative pain can result in alterations of which physiological
functions?

#

1

Field Minimum Maximum Mean
Poorly managed acute postoperative pain can result in
alterations of which
physiological functions?

1.00

4.00

3.33

Std
Variance Count
Deviation
1.25

1.56

9

#

Answer

%

Count

1

Increase myocardial demand

22.22%

2

2

Hypoventilation

0.00%

0

3

Impaired immune function

0.00%

0

4

All of the above

77.78%

7

Total

100%

9
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Q11 - Methadone’s clinical effect can be attributed to what three essential mechanisms of actions?

#
1

#

Field Minimum Maximum Mean
Methadone’s clinical effect can
be attributed to what three
essential mechanisms of actions?

1.00

2.00

1.22

Std
Variance Count
Deviation
0.42

Answer

0.17

9

% Count

Potent μ-receptor agonist, N-Methyl-D-aspartate receptor antagonist, and
77.78%
Reuptake inhibition of serotonin and norepinephrine

7

2 Delta receptor antagonist, kappa receptor antagonist, and sodium channel blocker 22.22%

2

3

Non-selective alpha antagonist, beta adrenergic antagonist, GABA-B antagonist

0.00%

0

4

Inhibition of alpha 2 delta subunit of voltage gated calcium channels, GABA-A
agonist, and muscarinic antagonist

0.00%

0

Total

100%

9

1

72
Q12 - Select the opioid with the longest elimination half-life:

#
1

Field Minimum Maximum Mean
Select the opioid with the
longest elimination half-life:

1.00

3.00

1.22

Std
Variance Count
Deviation
0.63

0.40

9

#

Answer

%

Count

1

Methadone

88.89%

8

2

Fentanyl

0.00%

0

3

Morphine

11.11%

1

4

Remifentanil

0.00%

0

Total

100%

9
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Q13 - Select the effect site equilibration of intravenous bolus dose of methadone

#
1

Field Minimum Maximum Mean
Select the effect site
equilibration of intravenous
bolus dose of methadone

2.00

3.00

Std
Variance Count
Deviation

2.22

0.42

0.17

9

#

Answer

%

Count

1

60 minutes

0.00%

0

2

7-8 minutes

77.78%

7

3

30 minutes

22.22%

2

4

1 minute

0.00%

0

Total

100%

9
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Q14 - What population of surgical patients can benefit from the clinical effects of methadone
administration?

#

1

Field Minimum Maximum Mean
What population of surgical
patients can benefit from the
clinical effects of methadone
administration?

5.00

5.00

5.00

Std
Variance Count
Deviation
0.00

0.00

9

#

Answer

%

Count

1

Spinal fusion

0.00%

0

2

Open abdominal

0.00%

0

3

Orthopedic

0.00%

0

4

Bariatric

0.00%

0

5

All of the above

100.00%

9

Total

100%

9

75
Q15 - A single dose of methadone 0.15-0.2 mg/kg administered on the induction of anesthesia
produces what clinical effects?

#

1

#
1

Field Minimum Maximum Mean
A single dose of methadone
0.15-0.2 mg/kg administered on
the induction of anesthesia
produces what clinical effects?

1.00

1.00

1.00

Std
Variance Count
Deviation
0.00

Answer

0.00

9

% Count

Potent intraoperative analgesia, long lasting post-operative analgesia, and
100.00%
reduction of post-operative opioid consumption up to 48 hours after surgery

9

2

Torsades de Pointes

0.00%

0

3

Opioid dependence

0.00%

0

4

Prolonged extubation time

0.00%

0

Total

100%

9

76
Q16 - Peak respiratory depressant effect of methadone occurs at what time after administration?

#
1

Field Minimum Maximum Mean
Peak respiratory depressant
effect of methadone occurs at
what time after administration?

1.00

2.00

1.11

Std
Variance Count
Deviation
0.31

0.10

9

#

Answer

%

Count

1

60-120 minutes

88.89%

8

2

8-10 minutes

11.11%

1

3

5 minutes

0.00%

0

4

1 minute

0.00%

0

Total

100%

9

77
Q17 - A patient received methadone 0.15 mg/kg on induction of anesthesia and is now displaying
persistent signs of severe pain with surgical stimulation. Select the best intervention.

#

1

Field Minimum Maximum Mean
A patient received methadone
0.15 mg/kg on induction of
anesthesia and is now displaying
persistent signs of severe pain
with surgical stimulation. Select
the best intervention.

2.00

4.00

2.22

Std
Variance Count
Deviation

0.63

0.40

9

#

Answer

%

Count

1

Re-dose methadone 0.15mg/kg

0.00%

0

2

Administer a rapid-acting opioid (i.e., fentanyl, remifentanil, alfentanil)

88.89%

8

3

Administer a muscle relaxant

0.00%

0

4

No intervention is required

11.11%

1

Total

100%

9

78
Q18 - What dose range of methadone is appropriate to administer on induction of anesthesia?

#
1

Field Minimum Maximum Mean
What dose range of methadone
is appropriate to administer on
induction of anesthesia?

1.00

1.00

1.00

Std
Variance Count
Deviation
0.00

0.00

9

#

Answer

%

Count

1

0.15-0.2 mg/kg (max of 20mg)

100.00%

9

2

1-2 mg/kg

0.00%

0

3

5 mg/kg

0.00%

0

4

10 mg/kg

0.00%

0

Total

100%

9

79
Q19 - Methadone should be excluded from patients presenting for elective surgery with which
disease process.

#

1

Field Minimum Maximum Mean
Methadone should be excluded
from patients presenting for
elective surgery with which
disease process.

2.00

4.00

3.78

Std
Variance Count
Deviation
0.63

0.40

9

#

Answer

%

Count

1

Impaired renal function

0.00%

0

2

Impaired hepatic function

11.11%

1

3

Obesity

0.00%

0

4

Both A and B

88.89%

8

Total

100%

9

80
Q20 - Select the best intervention if respiratory depression is evident and suspected to be attributed
to methadone administration.

#

1

Field Minimum Maximum Mean
Select the best intervention if
respiratory depression is evident
and suspected to be attributed to
methadone administration.

3.00

4.00

Std
Variance Count
Deviation

3.22

0.42

0.17

9

#

Answer

%

Count

1

Consider single flumazenil bolus 0.2mg

0.00%

0

2

Consider single glucagon bolus 1mg

0.00%

0

3

Consider single naloxone bolus 0.1mg

77.78%

7

4

Consider naloxone infusion 0.25-6.25 mg/hr

22.22%

2

Total

100%

9

81
Q21 - How likely are you to use alternative therapies in surgical patients to reduce post-operative
opioid consumption?

#

1

Field Minimum Maximum Mean
How likely are you to use
alternative therapies in surgical
patients to reduce post-operative
opioid consumption?

1.00

2.00

1.44

Std
Variance Count
Deviation
0.50

0.25

9

#

Answer

%

Count

1

Extremely

55.56%

5

2

Somewhat likely

44.44%

4

3

Neither likely nor unlikely

0.00%

0

4

Somewhat unlikely

0.00%

0

5

Extremely unlikely

0.00%

0

Total

100%

9

82
Q22 - How likely are you to utilize a single intraoperative dose of methadone to reduce postoperative opioid consumption up to 48 hours after surgery?

#

1

Field Minimum Maximum Mean
How likely are you to utilize a
single intraoperative dose of
methadone to reduce postoperative opioid consumption up
to 48 hours after surgery?

1.00

3.00

2.11

Std
Variance Count
Deviation

0.74

0.54

9

#

Answer

%

Count

1

Extremely likely

22.22%

2

2

Somewhat likely

44.44%

4

3

Neither likely nor unlikely

33.33%

3

4

Somewhat unlikely

0.00%

0

5

Extremely unlikely

0.00%

0

Total

100%

9

83
Appendix F: Post-Assessment Survey Results Report
Q24 - The incidence of post-operative pain can be as high as:

#
1

Field Minimum Maximum Mean
The incidence of post-operative
pain can be as high as:

3.00

4.00

Std
Variance Count
Deviation

3.78

0.42

0.17

9

#

Answer

%

Count

1

20%

0.00%

0

2

40%

0.00%

0

3

60%

22.22%

2

4

80%

77.78%

7

Total

100%

9

84
Q25 - The incidence of acute post-operative pain transitioning to chronic surgical pain can occur in
what percentage of patients undergoing surgical procedures:

#

1

Field Minimum Maximum Mean
The incidence of acute postoperative pain transitioning to
chronic surgical pain can occur
in what percentage of patients
undergoing surgical procedures:

1.00

3.00

Std
Variance Count
Deviation

1.44

0.83

0.69

9

#

Answer

%

Count

1

10-15%

77.78%

7

2

0%

0.00%

0

3

50%

22.22%

2

4

100%

0.00%

0

Total

100%

9

85
Q26 - Poorly managed acute post-operative pain can result in alterations of which physiological
functions?

#

1

Field Minimum Maximum Mean
Poorly managed acute postoperative pain can result in
alterations of which
physiological functions?

4.00

4.00

4.00

Std
Variance Count
Deviation
0.00

0.00

9

#

Answer

%

Count

1

Increase myocardial demand

0.00%

0

2

Hypoventilation

0.00%

0

3

Impaired immune function

0.00%

0

4

All of the above

100.00%

9

Total

100%

9

86
Q27 - Methadone’s clinical effect can be attributed to what three essential mechanisms of actions?

#
1

#
1
2

Field Minimum Maximum Mean
Methadone’s clinical effect can
be attributed to what three
essential mechanisms of actions?

1.00

1.00

1.00

Std
Variance Count
Deviation
0.00

Answer

0.00

9

% Count

Potent μ-receptor agonist, N-Methyl-D-aspartate receptor antagonist, and
100.00%
Reuptake inhibition of serotonin and norepinephrine
Delta receptor antagonist, kappa receptor antagonist, and sodium channel
0.00%
blocker

9
0

3

Non-selective alpha antagonist, beta adrenergic antagonist, GABA-B antagonist

0.00%

0

4

Inhibition of alpha 2 delta subunit of voltage gated calcium channels, GABA-A
agonist, and muscarinic antagonist

0.00%

0

Total

100%

9

87
Q28 - Select the opioid with the longest elimination half-life:

#
1

Field Minimum Maximum Mean
Select the opioid with the
longest elimination half-life:

1.00

1.00

1.00

Std
Variance Count
Deviation
0.00

0.00

9

#

Answer

%

Count

1

Methadone

100.00%

9

2

Fentanyl

0.00%

0

3

Morphine

0.00%

0

4

Remifentanil

0.00%

0

Total

100%

9

88
Q29 - Select the effect site equilibration of intravenous bolus dose of methadone

#
1

Field Minimum Maximum Mean
Select the effect site
equilibration of intravenous
bolus dose of methadone

2.00

2.00

2.00

Std
Variance Count
Deviation
0.00

0.00

9

#

Answer

%

Count

1

60 minutes

0.00%

0

2

7-8 minutes

100.00%

9

3

30 minutes

0.00%

0

4

1 minute

0.00%

0

Total

100%

9

89
Q30 - What population of surgical patients can benefit from the clinical effects of methadone
administration?

#

1

Field Minimum Maximum Mean
What population of surgical
patients can benefit from the
clinical effects of methadone
administration?

5.00

5.00

5.00

Std
Variance Count
Deviation
0.00

0.00

9

#

Answer

%

Count

1

Spinal fusion

0.00%

0

2

Open abdominal

0.00%

0

3

Orthopedic

0.00%

0

4

Bariatric

0.00%

0

5

All of the above

100.00%

9

Total

100%

9

90
Q31 - A single dose of methadone 0.15-0.2 mg/kg administered on the induction of anesthesia
produces what clinical effects?

#

1

#
1

Field Minimum Maximum Mean
A single dose of methadone
0.15-0.2 mg/kg administered on
the induction of anesthesia
produces what clinical effects?

1.00

1.00

1.00

Std
Variance Count
Deviation
0.00

Answer

0.00

9

% Count

Potent intraoperative analgesia, long lasting post-operative analgesia, and
100.00%
reduction of post-operative opioid consumption up to 48 hours after surgery

9

2

Torsades de Pointes

0.00%

0

3

Opioid dependence

0.00%

0

4

Prolonged extubation time

0.00%

0

Total

100%

9

91
Q32 - Peak respiratory depressant effect of methadone occurs at what time after administration?

#
1

Field Minimum Maximum Mean
Peak respiratory depressant
effect of methadone occurs at
what time after administration?

1.00

2.00

1.78

Std
Variance Count
Deviation
0.42

0.17

9

#

Answer

%

Count

1

60-120 minutes

22.22%

2

2

8-10 minutes

77.78%

7

3

5 minutes

0.00%

0

4

1 minute

0.00%

0

Total

100%

9

92
Q33 - A patient received methadone 0.15 mg/kg on induction of anesthesia and is now displaying
persistent signs of severe pain with surgical stimulation. Select the best intervention.

#

1

Field Minimum Maximum Mean
A patient received methadone
0.15 mg/kg on induction of
anesthesia and is now displaying
persistent signs of severe pain
with surgical stimulation. Select
the best intervention.

2.00

2.00

2.00

Std
Variance Count
Deviation

0.00

0.00

9

#

Answer

%

Count

1

Re-dose methadone 0.15mg/kg

0.00%

0

2

Administer a rapid-acting opioid (i.e., fentanyl, remifentanil, alfentanil)

100.00%

9

3

Administer a muscle relaxant

0.00%

0

4

No intervention is required

0.00%

0

Total

100%

9

93
Q34 - What dose range of methadone is appropriate to administer on induction of anesthesia?

#
1

Field Minimum Maximum Mean
What dose range of methadone
is appropriate to administer on
induction of anesthesia?

1.00

1.00

1.00

Std
Variance Count
Deviation
0.00

0.00

9

#

Answer

%

Count

1

0.15-0.2 mg/kg (max of 20mg)

100.00%

9

2

1-2 mg/kg

0.00%

0

3

5 mg/kg

0.00%

0

4

10 mg/kg

0.00%

0

Total

100%

9

94
Q35 - Methadone should be excluded from patients presenting for elective surgery with which
disease process.

#

1

Field Minimum Maximum Mean
Methadone should be excluded
from patients presenting for
elective surgery with which
disease process.

4.00

4.00

4.00

Std
Variance Count
Deviation
0.00

0.00

9

#

Answer

%

Count

1

Impaired renal function

0.00%

0

2

Impaired hepatic function

0.00%

0

3

Obesity

0.00%

0

4

Both A and B

100.00%

9

Total

100%

9

95
Q36 - Select the best intervention if respiratory depression is evident and suspected to be attributed
to methadone administration.

#

1

Field Minimum Maximum Mean
Select the best intervention if
respiratory depression is evident
and suspected to be attributed to
methadone administration.

3.00

4.00

Std
Variance Count
Deviation

3.89

0.31

0.10

9

#

Answer

%

Count

1

Consider single flumazenil bolus 0.2mg

0.00%

0

2

Consider single glucagon bolus 1mg

0.00%

0

3

Consider single naloxone bolus 0.1mg

11.11%

1

4

Consider naloxone infusion 0.25-6.25 mg/hr

88.89%

8

Total

100%

9

96
Q37 - How likely are you to use alternative therapies in surgical patients to reduce post-operative
opioid consumption?

#

1

Field Minimum Maximum Mean
How likely are you to use
alternative therapies in surgical
patients to reduce post-operative
opioid consumption?

1.00

2.00

1.33

Std
Variance Count
Deviation
0.47

0.22

9

#

Answer

%

Count

1

Extremely

66.67%

6

2

Somewhat likely

33.33%

3

3

Neither likely nor unlikely

0.00%

0

4

Somewhat unlikely

0.00%

0

5

Extremely unlikely

0.00%

0

Total

100%

9

97
Q38 - How likely are you to utilize a single intraoperative dose of methadone to reduce postoperative opioid consumption up to 48 hours after surgery?

#

1

Field Minimum Maximum Mean
How likely are you to utilize a
single intraoperative dose of
methadone to reduce postoperative opioid consumption up
to 48 hours after surgery?

1.00

3.00

1.89

Std
Variance Count
Deviation

0.74

0.54

9

#

Answer

%

Count

1

Extremely likely

33.33%

3

2

Somewhat likely

44.44%

4

3

Neither likely nor unlikely

22.22%

2

4

Somewhat unlikely

0.00%

0

5

Extremely unlikely

0.00%

0

Total

100%

9

